Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Influenza

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 456 articles:
HTML format
Text format



Single Articles


    May 2017
  1. HENDIN HE, Pillet S, Lara AN, Wu CY, et al
    Plant-made virus-like particle vaccines bearing the hemagglutinin of either seasonal (H1) or avian (H5) influenza have distinct patterns of interaction with human immune cells in vitro.
    Vaccine. 2017;35:2592-2599.
    PubMed     Text format     Abstract available


    April 2017
  2. SUH J, Kim B, Yang Y, Suh DC, et al
    Cost effectiveness of influenza vaccination in patients with acute coronary syndrome in Korea.
    Vaccine. 2017 Apr 17. pii: S0264-410X(17)30480.
    PubMed     Text format     Abstract available


  3. DAUNER A, Agrawal P, Salvatico J, Tapia T, et al
    The in vitro MIMIC(R) platform reflects age-associated changes in immunological responses after influenza vaccination.
    Vaccine. 2017 Apr 13. pii: S0264-410X(17)30451.
    PubMed     Text format     Abstract available


  4. VAN DOORN E, Darvishian M, Dijkstra F, Donker GA, et al
    Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups.
    Vaccine. 2017 Apr 12. pii: S0264-410X(17)30476.
    PubMed     Text format     Abstract available


  5. BERLANDA SCORZA F
    Advancing new vaccines against pandemic influenza in low-resource countries.
    Vaccine. 2017 Apr 11. pii: S0264-410X(17)30446.
    PubMed     Text format     Abstract available


  6. MCLEAN HQ, Caspard H, Griffin MR, Poehling KA, et al
    Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    Vaccine. 2017 Apr 10. pii: S0264-410X(17)30437.
    PubMed     Text format     Abstract available


  7. RAY GT, Lewis N, Goddard K, Ross P, et al
    Asthma exacerbations among asthmatic children receiving live attenuated versus inactivated influenza vaccines.
    Vaccine. 2017 Apr 9. pii: S0264-410X(17)30434.
    PubMed     Text format     Abstract available


  8. HOFSTETTER AM, Robinson JD, Lepere K, Cunningham M, et al
    Clinician-parent discussions about influenza vaccination of children and their association with vaccine acceptance.
    Vaccine. 2017 Apr 6. pii: S0264-410X(17)30411.
    PubMed     Text format     Abstract available


  9. AIREY J, Albano FR, Sawlwin DC, Jones AG, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study.
    Vaccine. 2017 Apr 5. pii: S0264-410X(17)30334.
    PubMed     Text format     Abstract available


  10. LEUNG VK, Carolan LA, Worth LJ, Harper SA, et al
    Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers.
    Vaccine. 2017 Apr 3. pii: S0264-410X(17)30390.
    PubMed     Text format     Abstract available


    March 2017
  11. IMBURGIA TM, Hendrix KS, Donahue KL, Sturm LA, et al
    Predictors of influenza vaccination in the U.S. among children 9-13years of age.
    Vaccine. 2017 Mar 27. pii: S0264-410X(17)30387.
    PubMed     Text format     Abstract available


  12. OFSTEAD CL, Amelang MR, Wetzler HP, Tan L, et al
    Moving the needle on nursing staff influenza vaccination in long-term care: Results of an evidence-based intervention.
    Vaccine. 2017 Mar 25. pii: S0264-410X(17)30357.
    PubMed     Text format     Abstract available


  13. HELLFRITZSCH M, Thomsen RW, Baggesen LM, Larsen FB, et al
    Lifestyle, socioeconomic characteristics, and medical history of elderly persons who receive seasonal influenza vaccination in a tax-supported healthcare system.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30356.
    PubMed     Text format     Abstract available


  14. FELL DB, Bhutta ZA, Hutcheon JA, Karron RA, et al
    Report of the WHO technical consultation on the effect of maternal influenza and influenza vaccination on the developing fetus: Montreal, Canada, September 30-October 1, 2015.
    Vaccine. 2017 Mar 23. pii: S0264-410X(17)30373.
    PubMed     Text format     Abstract available


  15. TSENG YF, Weng TC, Lai CC, Chen PL, et al
    A fast and efficient purification platform for cell-based influenza viruses by flow-through chromatography.
    Vaccine. 2017 Mar 22. pii: S0264-410X(17)30322.
    PubMed     Text format     Abstract available


  16. KOEPKE R, Schauer SL, Davis JP
    Measuring maternal Tdap and influenza vaccination rates: Comparison of two population-based methods.
    Vaccine. 2017 Mar 21. pii: S0264-410X(17)30330.
    PubMed     Text format     Abstract available


  17. KANG GJ, Culp RK, Abbas KM
    Facilitators and barriers of parental attitudes and beliefs toward school-located influenza vaccination in the United States: Systematic review.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30320.
    PubMed     Text format     Abstract available


  18. GUIOMAR R, Pereira da Silva S, Conde P, Cristovao P, et al
    Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal.
    Vaccine. 2017 Mar 15. pii: S0264-410X(17)30213.
    PubMed     Text format     Abstract available


  19. LANSBURY LE, Smith S, Beyer W, Karamehic E, et al
    Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis.
    Vaccine. 2017 Mar 14. pii: S0264-410X(17)30272.
    PubMed     Text format     Abstract available


  20. TREANOR JT, Albano FR, Sawlwin DC, Graves Jones A, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine compared with two trivalent inactivated influenza vaccines containing alternate B strains in adults: A phase 3, randomized noninferiority study.
    Vaccine. 2017 Mar 13. pii: S0264-410X(17)30291.
    PubMed     Text format     Abstract available


  21. TROGSTAD L, Bakken IJ, Gunnes N, Ghaderi S, et al
    Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic.
    Vaccine. 2017 Mar 13. pii: S0264-410X(17)30266.
    PubMed     Text format     Abstract available


  22. SEQUEIRA DP, Correia R, Carrondo MJ, Roldao A, et al
    Combining stable insect cell lines with baculovirus-mediated expression for multi-HA influenza VLP production.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30246.
    PubMed     Text format     Abstract available


  23. MOSNIER A, Daviaud I, Caini S, Berche H, et al
    Does seasonal vaccination affect the clinical presentation of influenza among the elderly? A cross-sectional analysis in the outpatient setting in France, 2003-2014.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30292.
    PubMed     Text format     Abstract available


  24. UI H, Yamayoshi S, Uraki R, Kiso M, et al
    Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus.
    Vaccine. 2017 Mar 9. pii: S0264-410X(17)30244.
    PubMed     Text format     Abstract available


  25. TING EE, Sander B, Ungar WJ
    Systematic review of the cost-effectiveness of influenza immunization programs.
    Vaccine. 2017 Mar 8. pii: S0264-410X(17)30247.
    PubMed     Text format     Abstract available


  26. PROBST P, Grigg JB, Wang M, Munoz E, et al
    A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.
    Vaccine. 2017 Mar 6. pii: S0264-410X(17)30118.
    PubMed     Text format     Abstract available


  27. KUCK LR, Saye S, Loob S, Roth-Eichhorn S, et al
    VaxArray assessment of influenza split vaccine potency and stability.
    Vaccine. 2017 Mar 2. pii: S0264-410X(17)30222.
    PubMed     Text format     Abstract available


    February 2017
  28. SMITH LE, Webster RK, Weinman J, Amlot R, et al
    Psychological factors associated with uptake of the childhood influenza vaccine and perception of post-vaccination side-effects: A cross-sectional survey in England.
    Vaccine. 2017 Feb 24. pii: S0264-410X(17)30225.
    PubMed     Text format     Abstract available


  29. CHEUNG K, Ho SM, Lam W
    Factors affecting the willingness of nursing students to receive annual seasonal influenza vaccination: A large-scale cross-sectional study.
    Vaccine. 2017 Feb 14. pii: S0264-410X(17)30164.
    PubMed     Text format     Abstract available


  30. MEIJER WJ, Wensing AM, Bos AA, Kuiphuis JC, et al
    Influenza vaccination in healthcare workers; comparison of side effects and preferred route of administration of intradermal versus intramuscular administration.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30145.
    PubMed     Text format     Abstract available


  31. MCHUGH L, Andrews RM, Lambert SB, Viney KA, et al
    Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30155.
    PubMed     Text format     Abstract available


  32. LENNY BJ, Sonnberg S, Danner AF, Friedman K, et al
    Evaluation of multivalent H2 influenza pandemic vaccines in mice.
    Vaccine. 2017 Feb 8. pii: S0264-410X(17)30061.
    PubMed     Text format     Abstract available


  33. WUMKES ML, van der Velden AM, de Bruin E, Meerveld-Eggink A, et al
    Microarray profile of the humoral immune response to influenza vaccination in breast cancer patients treated with chemotherapy.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30088.
    PubMed     Text format     Abstract available


  34. YUK SS, Erdene-Ochir TO, Kwon JH, Noh JY, et al
    Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.
    Vaccine. 2017 Feb 3. pii: S0264-410X(17)30082.
    PubMed     Text format     Abstract available


  35. BAXTER R, Eaton A, Hansen J, Aukes L, et al
    Safety of quadrivalent live attenuated influenza vaccine in subjects aged 2-49years.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30128.
    PubMed     Text format     Abstract available


  36. SANCHEZ-RAMOS EL, Monarrez-Espino J, Noyola DE
    Impact of vaccination on influenza mortality in children <5years old in Mexico.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30087.
    PubMed     Text format     Abstract available


  37. BARMAN S, Krylov PS, Turner JC, Franks J, et al
    Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs.
    Vaccine. 2017 Feb 2. pii: S0264-410X(17)30127.
    PubMed     Text format     Abstract available


    January 2017
  38. ALAN H, Ian B, Nancy C, Ruben O D, et al
    Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015.
    Vaccine. 2017 Jan 25. pii: S0264-410X(17)30037.
    PubMed     Text format     Abstract available


  39. SMALL PA JR, Cronin BJ
    The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection.
    Vaccine. 2017 Jan 21. pii: S0264-410X(17)30041.
    PubMed     Text format    


  40. DHAKAL S, Goodman J, Bondra K, Lakshmanappa YS, et al
    Polyanhydride nanovaccine against swine influenza virus in pigs.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30038.
    PubMed     Text format     Abstract available


  41. MORIYAMA M, Chino S, Ichinohe T
    Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge.
    Vaccine. 2017 Jan 19. pii: S0264-410X(17)30046.
    PubMed     Text format     Abstract available


  42. DAVID SC, Lau J, Singleton EV, Babb R, et al
    The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.
    Vaccine. 2017 Jan 18. pii: S0264-410X(16)31269.
    PubMed     Text format     Abstract available


  43. NAKAYAMA M, Itoh Y, Shichinohe S, Nakabayashi R, et al
    Potential risk of repeated nasal vaccination that induces allergic reaction with mucosal IgE and airway eosinophilic infiltration in cynomolgus macaques infected with H5N1 highly pathogenic avian influenza virus.
    Vaccine. 2017 Jan 18. pii: S0264-410X(17)30013.
    PubMed     Text format     Abstract available


  44. YANG L, Nan H, Liang J, Chan YH, et al
    Influenza vaccination in older people with diabetes and their household contacts.
    Vaccine. 2017 Jan 13. pii: S0264-410X(17)30007.
    PubMed     Text format     Abstract available


  45. TREANOR JJ, Chu L, Essink B, Muse D, et al
    Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
    Vaccine. 2017 Jan 11. pii: S0264-410X(16)31286.
    PubMed     Text format     Abstract available


  46. ZHANG W, Hirve S, Kieny MP
    Seasonal vaccines - Critical path to pandemic influenza response.
    Vaccine. 2017 Jan 10. pii: S0264-410X(16)31289.
    PubMed     Text format    


  47. COWLING BJ, Caini S, Chotpitayasunondh T, Djauzi S, et al
    Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative.
    Vaccine. 2017 Jan 9. pii: S0264-410X(16)31298.
    PubMed     Text format     Abstract available


  48. NEROME K, Matsuda S, Maegawa K, Sugita S, et al
    Quantitative analysis of the yield of avian H7 influenza virus haemagglutinin protein produced in silkworm pupae with the use of the codon-optimized DNA: A possible oral vaccine.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31291.
    PubMed     Text format     Abstract available


  49. LOWELL GH, Ziv S, Bruzil S, Babecoff R, et al
    Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain.
    Vaccine. 2017 Jan 5. pii: S0264-410X(16)31297.
    PubMed     Text format     Abstract available


  50. LIN J, Xia J, Chen YT, Zhang KY, et al
    H9N2 avian influenza virus enhances the immune responses of BMDCs by down-regulating miR29c.
    Vaccine. 2017 Jan 4. pii: S0264-410X(16)31287.
    PubMed     Text format     Abstract available


  51. YUDIN MH, Mistry N, De Souza LR, Besel K, et al
    Text messages for influenza vaccination among pregnant women: A randomized controlled trial.
    Vaccine. 2017 Jan 3. pii: S0264-410X(16)31195.
    PubMed     Text format     Abstract available


    December 2016
  52. SAITO N, Komori K, Suzuki M, Morimoto K, et al
    Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)31071.
    PubMed     Text format     Abstract available


  53. MILLMAN AJ, Reynolds S, Duffy J, Chen J, et al
    Hospitalizations within 14days of vaccination among pediatric recipients of the live attenuated influenza vaccine, United States 2010-2012.
    Vaccine. 2016 Dec 29. pii: S0264-410X(16)31258.
    PubMed     Text format     Abstract available


  54. LEE TY, Kim CU, Bae EH, Seo SH, et al
    Outer membrane vesicles harboring modified lipid A moiety augment the efficacy of an influenza vaccine exhibiting reduced endotoxicity in a mouse model.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31232.
    PubMed     Text format     Abstract available


  55. DOMNICH A, Arata L, Amicizia D, Puig-Barbera J, et al
    Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31218.
    PubMed     Text format     Abstract available


  56. MERTZ D, Geraci J, Winkup J, Gessner BD, et al
    Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies.
    Vaccine. 2016 Dec 23. pii: S0264-410X(16)31219.
    PubMed     Text format     Abstract available


  57. POWELL AM, Luo Z, Martin L, Wan Z, et al
    The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31233.
    PubMed     Text format     Abstract available


  58. YOUNG B, Zhao X, Cook AR, Parry CM, et al
    Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis.
    Vaccine. 2016 Dec 7. pii: S0264-410X(16)31044.
    PubMed     Text format     Abstract available


  59. PILKINTON MA, Nicholas KJ, Warren CM, Smith RM, et al
    Greater activation of peripheral T follicular helper cells following high dose influenza vaccine in older adults forecasts seroconversion.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31121.
    PubMed     Text format     Abstract available


  60. SONG JY, Cheong HJ, Hyun HJ, Seo YB, et al
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine and an MF59-adjuvanted influenza vaccine after concomitant vaccination in 60-year-old adults.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31109.
    PubMed     Text format     Abstract available


  61. CHONG Y, Ikematsu H
    Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31156.
    PubMed     Text format     Abstract available


  62. HULO S, Nuvoli A, Sobaszek A, Salembier-Trichard A, et al
    Knowledge and attitudes towards influenza vaccination of health care workers in emergency services.
    Vaccine. 2016 Dec 2. pii: S0264-410X(16)31158.
    PubMed     Text format     Abstract available


    November 2016
  63. ZHOU H, Huang Y, Yuan S, Li Y, et al
    Sequential immunization with consensus influenza hemagglutinins raises cross-reactive neutralizing antibodies against various heterologous HA strains.
    Vaccine. 2016 Nov 30. pii: S0264-410X(16)31113.
    PubMed     Text format     Abstract available


  64. DE VRIES RD, Nieuwkoop NJ, Pronk M, de Bruin E, et al
    Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.
    Vaccine. 2016 Nov 30. pii: S0264-410X(16)31154.
    PubMed     Text format     Abstract available


  65. VAN BAALEN CA, Jeeninga RE, Penders GH, van Gent B, et al
    ViroSpot microneutralization assay for antigenic characterization of human influenza viruses.
    Vaccine. 2016 Nov 26. pii: S0264-410X(16)31122.
    PubMed     Text format     Abstract available


  66. WANEESORN J, Wibowo N, Bingham J, Middelberg AP, et al
    Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31120.
    PubMed     Text format     Abstract available


  67. JIMENEZ-GARCIA R, Lopez-de-Andres A, Hernandez-Barrera V, Gomez-Campelo P, et al
    Influenza vaccination in people with type 2 diabetes, coverage, predictors of uptake, and perceptions. Result of the MADIABETES cohort a 7years follow up study.
    Vaccine. 2016 Nov 24. pii: S0264-410X(16)31100.
    PubMed     Text format     Abstract available


  68. SHEN Z, Bowen RA, Ge P, Yu J, et al
    Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets.
    Vaccine. 2016;34:5953-5958.
    PubMed     Text format     Abstract available


  69. ZHENG D, Chen S, Qu D, Chen J, et al
    Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31073.
    PubMed     Text format     Abstract available


  70. KANG J, Song YM
    Factors associated with vaccination status among Korean submariners who are eligible for free non-mandatory influenza vaccination.
    Vaccine. 2016 Nov 10. pii: S0264-410X(16)31027.
    PubMed     Text format     Abstract available


  71. WALKER L, Newall A, Heywood AE
    Knowledge, attitudes and practices of Australian medical students towards influenza vaccination.
    Vaccine. 2016 Nov 8. pii: S0264-410X(16)31024.
    PubMed     Text format     Abstract available


  72. HUANG CH, Chao DY, Wu CC, Hsu SY, et al
    Influenza vaccination and the endurance against air pollution among elderly with acute coronary syndrome.
    Vaccine. 2016 Nov 4. pii: S0264-410X(16)30989.
    PubMed     Text format     Abstract available


  73. PIELER MM, Frentzel S, Bruder D, Wolff MW, et al
    A cell culture-derived whole virus influenza A vaccine based on magnetic sulfated cellulose particles confers protection in mice against lethal influenza A virus infection.
    Vaccine. 2016 Nov 2. pii: S0264-410X(16)30976.
    PubMed     Text format     Abstract available


    October 2016
  74. LIU H, Frijlink HW, Huckriede A, van Doorn E, et al
    Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30975.
    PubMed     Text format     Abstract available


  75. MANENTI A, Tete SM, Mohn KG, Jul-Larsen A, et al
    Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
    Vaccine. 2016 Oct 24. pii: S0264-410X(16)30940.
    PubMed     Text format     Abstract available


  76. DVALISHVILI M, Mesxishvili D, Butsashvili M, Kamkamidze G, et al
    Knowledge, attitudes, and practices of healthcare providers in the country of Georgia regarding influenza vaccinations for pregnant women.
    Vaccine. 2016 Oct 20. pii: S0264-410X(16)30954.
    PubMed     Text format     Abstract available


  77. YANG J, Atkins KE, Feng L, Pang M, et al
    Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis.
    Vaccine. 2016 Oct 13. pii: S0264-410X(16)30911.
    PubMed     Text format     Abstract available


  78. KARKI S, Dyda A, Newall A, Heywood A, et al
    Comparison of influenza vaccination coverage between immigrant and Australian-born adults.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30910.
    PubMed     Text format     Abstract available


  79. MAERTENS K, Braeckman T, Top G, Van Damme P, et al
    Maternal pertussis and influenza immunization coverage and attitude of health care workers towards these recommendations in Flanders, Belgium.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30882.
    PubMed     Text format     Abstract available


  80. SITARAS I, Rousou X, Peeters B, de Jong MC, et al
    Mutations in the haemagglutinin protein and their effect in transmission of highly pathogenic avian influenza (HPAI) H5N1 virus in sub-optimally vaccinated chickens.
    Vaccine. 2016 Oct 8. pii: S0264-410X(16)30894.
    PubMed     Text format     Abstract available


  81. ABADOM TR, Smith AD, Tempia S, Madhi SA, et al
    Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study.
    Vaccine. 2016 Oct 6. pii: S0264-410X(16)30824.
    PubMed     Text format     Abstract available


    September 2016
  82. FITZGERALD TJ, Kang Y, Bridges CB, Talbert T, et al
    Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
    Vaccine. 2016 Sep 26. pii: S0264-410X(16)30833.
    PubMed     Text format     Abstract available


  83. GELLIN BG, Qadri F
    Preparing for the unpredictable: The continuing need for pandemic influenza preparedness.
    Vaccine. 2016 Sep 24. pii: S0264-410X(16)30836.
    PubMed     Text format    


  84. LIN X, Fiebelkorn AP, Pabst LJ
    Trends in compliance with two-dose influenza vaccine recommendations in children aged 6 months through 8 years, 2010-2015.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30850.
    PubMed     Text format     Abstract available


  85. WILLIS E, Parkhouse K, Krammer F, Hensley SE, et al
    Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States.
    Vaccine. 2016 Sep 23. pii: S0264-410X(16)30830.
    PubMed     Text format     Abstract available


  86. LEVIN Y, Kochba E, Shukarev G, Rusch S, et al
    A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30804.
    PubMed     Text format     Abstract available


  87. WONG VW, Fong DY, Lok KY, Wong JY, et al
    Brief education to promote maternal influenza vaccine uptake: A randomized controlled trial.
    Vaccine. 2016 Sep 22. pii: S0264-410X(16)30832.
    PubMed     Text format     Abstract available


  88. SLAUNWHITE JM, Smith SM, Halperin BA, Langley JM, et al
    The role of healthcare provider attitudes in increasing willingness to accept seasonal influenza vaccine policy changes.
    Vaccine. 2016 Sep 21. pii: S0264-410X(16)30790.
    PubMed     Text format     Abstract available


  89. PUSHKO P, Sun X, Tretyakova I, Hidajat R, et al
    Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model.
    Vaccine. 2016 Sep 20. pii: S0264-410X(16)30825.
    PubMed     Text format     Abstract available


  90. ORTIZ JR, Perut M, Dumolard L, Wijesinghe PR, et al
    A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization.
    Vaccine. 2016 Sep 16. pii: S0264-410X(16)30643.
    PubMed     Text format     Abstract available


  91. NANNEI C, Goldin S, Torelli G, Fatima H, et al
    Stakeholders' perceptions of 10years of the Global Action Plan for Influenza Vaccines (GAP) - Results from a survey.
    Vaccine. 2016 Sep 16. pii: S0264-410X(16)30712.
    PubMed     Text format     Abstract available


  92. SPARROW E, Friede M, Sheikh M, Torvaldsen S, et al
    Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications.
    Vaccine. 2016 Sep 9. pii: S0264-410X(16)30744.
    PubMed     Text format     Abstract available


  93. SCHMIDT R, Holznagel E, Neumann B, Alex N, et al
    Squalene-containing licensed adjuvants enhance strain-specific antibody responses against the influenza hemagglutinin and induce subtype-specific antibodies against the neuraminidase.
    Vaccine. 2016 Sep 8. pii: S0264-410X(16)30789.
    PubMed     Text format     Abstract available


  94. SULLIVAN SG, Cowling BJ, Greenland S
    Frailty and influenza vaccine effectiveness.
    Vaccine. 2016;34:4645-6.
    PubMed     Text format    


  95. NANNEI C, Chadwick C, Fatima H, Goldin S, et al
    Considerations for sustainable influenza vaccine production in developing countries.
    Vaccine. 2016 Sep 7. pii: S0264-410X(16)30743.
    PubMed     Text format     Abstract available


  96. CASPARD H, Coelingh KL, Mallory RM, Ambrose CS, et al
    Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States.
    Vaccine. 2016 Sep 6. pii: S0264-410X(16)30786.
    PubMed     Text format     Abstract available


  97. TABYNOV K, Orynbayev M, Renukaradhya GJ, Sansyzbay A, et al
    Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine.
    Vaccine. 2016 Sep 2. pii: S0264-410X(16)30768.
    PubMed     Text format     Abstract available


  98. SARAWAR S, Hatta Y, Watanabe S, Dias P, et al
    M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice.
    Vaccine. 2016 Sep 2. pii: S0264-410X(16)30757.
    PubMed     Text format     Abstract available


  99. RUDENKO L, Yeolekar L, Kiseleva I, Isakova-Sivak I, et al
    Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.
    Vaccine. 2016 Sep 1. pii: S0264-410X(16)30675.
    PubMed     Text format     Abstract available


    August 2016
  100. PHAN TL, Ho VT, Vu MH, Nguyen TN, et al
    Clinical testing of an inactivated influenza A/H5N1 vaccine candidate in a double-blinded, placebo-controlled, randomized trial in healthy adults in Vietnam.
    Vaccine. 2016 Aug 31. pii: S0264-410X(16)30742.
    PubMed     Text format     Abstract available


  101. PROVEAUX T, Lambach P, Ortiz JR, Hombach J, et al
    Review of prescribing information for influenza vaccines for pregnant and lactating women.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30714.
    PubMed     Text format     Abstract available


  102. ASTRAY-MOCHALES J, Lopez de Andres A, Hernandez-Barrera V, Rodriguez-Rieiro C, et al
    Influenza vaccination coverages among high risk subjects and health care workers in Spain. Results of two consecutive National Health Surveys (2011-2014).
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30761.
    PubMed     Text format     Abstract available


  103. MCBRIDE WJ, Abhayaratna WP, Barr I, Booy R, et al
    Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial.
    Vaccine. 2016 Aug 29. pii: S0264-410X(16)30710.
    PubMed     Text format     Abstract available


  104. CRUM-CIANFLONE NF, Won S, Lee R, Lalani T, et al
    Vitamin D levels and influenza vaccine immunogenicity among HIV-infected and HIV-uninfected adults.
    Vaccine. 2016 Aug 28. pii: S0264-410X(16)30432.
    PubMed     Text format     Abstract available


  105. FIELDING JE, Levy A, Chilver MB, Deng YM, et al
    Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment.
    Vaccine. 2016 Aug 28. pii: S0264-410X(16)30763.
    PubMed     Text format     Abstract available


  106. GADROEN K, Straus SM, Pacurariu A, Weibel D, et al
    Patterns of spontaneous reports on narcolepsy following administration of pandemic influenza vaccine; a case series of individual case safety reports in Eudravigilance.
    Vaccine. 2016 Aug 27. pii: S0264-410X(16)30758.
    PubMed     Text format     Abstract available


  107. CHENG T, Wang X, Song Y, Tang X, et al
    Chimpanzee adenovirus vector-based avian influenza vaccine completely protects mice against lethal challenge of H5N1.
    Vaccine. 2016 Aug 26. pii: S0264-410X(16)30762.
    PubMed     Text format     Abstract available


  108. ANH DD, Thiem VD, Anh NT, Huong VM, et al
    Randomized safety and immunogenicity trial of a seasonal trivalent inactivated split virion influenza vaccine (IVACFLU-S) in healthy young Vietnamese adults.
    Vaccine. 2016 Aug 24. pii: S0264-410X(16)30739.
    PubMed     Text format     Abstract available


  109. SINGH SM, Alkie TN, Nagy E, Kulkarni RR, et al
    Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Vaccine. 2016 Aug 16. pii: S0264-410X(16)30666.
    PubMed     Text format     Abstract available


  110. MCLEAN KA, Goldin S, Nannei C, Sparrow E, et al
    The 2015 global production capacity of seasonal and pandemic influenza vaccine.
    Vaccine. 2016 Aug 13. pii: S0264-410X(16)30676.
    PubMed     Text format     Abstract available


  111. HOLBROOK BC, D'Agostino RB Jr, Parks GD, Alexander-Miller MA, et al
    Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model.
    Vaccine. 2016 Aug 8. pii: S0264-410X(16)30667.
    PubMed     Text format     Abstract available


  112. GROHMANN G, Francis DP, Sokhey J, Robertson J, et al
    Challenges and successes for the grantees and the Technical Advisory Group of WHO's influenza vaccine technology transfer initiative.
    Vaccine. 2016 Aug 6. pii: S0264-410X(16)30645.
    PubMed     Text format     Abstract available


  113. PALKONYAY L, Fatima H
    A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006-2016).
    Vaccine. 2016 Aug 3. pii: S0264-410X(16)30608.
    PubMed     Text format     Abstract available


    July 2016
  114. WAHID R, Holt R, Hjorth R, Berlanda Scorza F, et al
    Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers.
    Vaccine. 2016 Jul 30. pii: S0264-410X(16)30644.
    PubMed     Text format     Abstract available


  115. KIM JH, Talbot HK, Mishina M, Zhu Y, et al
    High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses.
    Vaccine. 2016 Jul 26. pii: S0264-410X(16)30591.
    PubMed     Text format     Abstract available


  116. PAN Y, Deem MW
    Prediction of influenza B vaccine effectiveness from sequence data.
    Vaccine. 2016 Jul 26. pii: S0264-410X(16)30588.
    PubMed     Text format     Abstract available


  117. LOUIK C, Kerr S, Van Bennekom CM, Chambers C, et al
    Safety of the 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Preterm delivery and specific malformations, a study from the case-control arm of VAMPSS.
    Vaccine. 2016 Jul 21. pii: S0264-410X(16)30558.
    PubMed     Text format     Abstract available


  118. CHAMBERS CD, Johnson DL, Xu R, Luo YJ, et al
    Safety of the 2010-11, 2011-12, 2012-13, and 2013-14 seasonal influenza vaccines in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants, a study from the cohort arm of VAMPSS.
    Vaccine. 2016 Jul 20. pii: S0264-410X(16)30478.
    PubMed     Text format     Abstract available


  119. BARDENHEIER BH, Duderstadt SK, Engler RJ, McNeil MM, et al
    Adverse events following pandemic influenza A (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting Sy
    Vaccine. 2016 Jul 19. pii: S0264-410X(16)30592.
    PubMed     Text format     Abstract available


  120. MOA AM, Chughtai AA, Muscatello DJ, Turner RM, et al
    Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials.
    Vaccine. 2016 Jul 2. pii: S0264-410X(16)30515.
    PubMed     Text format     Abstract available


    June 2016
  121. KEMMEREN J, Honsbeek M, Dijkstra F, de Lange M, et al
    Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination.
    Vaccine. 2016 Jun 24. pii: S0264-410X(16)30479.
    PubMed     Text format     Abstract available


  122. GORDON DL, Sajkov D, Honda-Okubo Y, Wilks SH, et al
    Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax delta inulin adjuvant.
    Vaccine. 2016 Jun 21. pii: S0264-410X(16)30397.
    PubMed     Text format     Abstract available


  123. SANDBULTE MR, Gauger PC, Kitikoon P, Chen H, et al
    Neuraminidase inhibiting antibody responses in pigs differ between influenza A virus N2 lineages and by vaccine type.
    Vaccine. 2016 Jun 17. pii: S0264-410X(16)30400.
    PubMed     Text format     Abstract available


  124. SUI J, Yang D, Qiao C, Xu H, et al
    Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice.
    Vaccine. 2016 Jun 16. pii: S0264-410X(16)30408.
    PubMed     Text format     Abstract available


  125. HARALAMBIEVA IH, Ovsyannikova IG, Kennedy RB, Zimmermann MT, et al
    Transcriptional signatures of influenza A/H1N1-specific IgG memory-like B cell response in older individuals.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30458.
    PubMed     Text format     Abstract available


  126. LEE GJ, Quan FS
    Protection induced by early stage vaccination with pandemic influenza virus-like particles.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30410.
    PubMed     Text format     Abstract available


  127. FELDSTEIN LR, Matrajt L, Elizabeth Halloran M, Keitel WA, et al
    Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.
    Vaccine. 2016 Jun 4. pii: S0264-410X(16)30393.
    PubMed     Text format     Abstract available


  128. FOUGEROLLE S, Legrand L, Garrett D, Birand I, et al
    Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.
    Vaccine. 2016 Jun 3. pii: S0264-410X(16)30394.
    PubMed     Text format     Abstract available


  129. RADIN JM, Hawksworth AW, Myers CA, Ricketts MN, et al
    Influenza vaccine effectiveness: Maintained protection throughout the duration of influenza seasons 2010-2011 through 2013-2014.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30324.
    PubMed     Text format     Abstract available


    May 2016
  130. GIESE C, Mereckiene J, Danis K, O'Donnell J, et al
    Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination.
    Vaccine. 2016 May 30. pii: S0264-410X(16)30318.
    PubMed     Text format     Abstract available


  131. MCCONEGHY KW, Wing C
    A national examination of pharmacy-based immunization statutes and their association with influenza vaccinations and preventive health.
    Vaccine. 2016 May 21. pii: S0264-410X(16)30241.
    PubMed     Text format     Abstract available


  132. HEQUET D, Pascual M, Lartey S, Pathirana RD, et al
    Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
    Vaccine. 2016 May 21. pii: S0264-410X(16)30311.
    PubMed     Text format     Abstract available


  133. SUPHAPHIPHAT P, Whittaker L, De Souza I, Daniels RS, et al
    Antigenic characterization of influenza viruses produced using synthetic DNA and novel backbones.
    Vaccine. 2016 May 21. pii: S0264-410X(16)30321.
    PubMed     Text format     Abstract available


  134. DOS SANTOS G, Haguinet F, Cohet C, Webb D, et al
    Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30299.
    PubMed     Text format     Abstract available


  135. REGAN AK, Klerk N, Moore HC, Omer SB, et al
    Effectiveness of seasonal trivalent influenza vaccination against hospital-attended acute respiratory infections in pregnant women: A retrospective cohort study.
    Vaccine. 2016 May 20. pii: S0264-410X(16)30322.
    PubMed     Text format     Abstract available


  136. THORNE A, Chowdhury F, Singer J, Keynan Y, et al
    Comparison of hemagglutination inhibition and microbead array assays for the measurement of influenza antibody levels in HIV-infected adults.
    Vaccine. 2016 May 19. pii: S0264-410X(16)30310.
    PubMed     Text format     Abstract available


  137. BORGGREN M, Nielsen J, Karlsson I, Dalgaard TS, et al
    A polyvalent influenza DNA vaccine applied by needle-free intradermal delivery induces cross-reactive humoral and cellular immune responses in pigs.
    Vaccine. 2016 May 19. pii: S0264-410X(16)30320.
    PubMed     Text format     Abstract available


  138. THOMPSON MG, Gaglani MJ, Naleway AL, Dowell SH, et al
    Reduced serologic sensitivity to influenza A virus illness among inactivated influenza vaccinees.
    Vaccine. 2016 May 16. pii: S0264-410X(16)30260.
    PubMed     Text format     Abstract available


  139. THOMAS RE
    Do we have enough evidence how seasonal influenza is transmitted and can be prevented in hospitals to implement a comprehensive policy?
    Vaccine. 2016 May 9. pii: S0264-410X(16)30271.
    PubMed     Text format     Abstract available


  140. KUSAKABE T, Ozasa K, Kobari S, Momota M, et al
    Intranasal hydroxypropyl-beta-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30121.
    PubMed     Text format     Abstract available


  141. XU J, Zhou F, Reed C, Chaves SS, et al
    Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women.
    Vaccine. 2016 May 5. pii: S0264-410X(16)30211.
    PubMed     Text format     Abstract available


  142. VENEREO-SANCHEZ A, Gilbert R, Simoneau M, Caron A, et al
    Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30264.
    PubMed     Text format     Abstract available


  143. BENNET R, Hamrin J, Wirgart BZ, Ostlund MR, et al
    Influenza epidemiology among hospitalized children in Stockholm, Sweden 1998-2014.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30256.
    PubMed     Text format     Abstract available


  144. WHITE JA, Estrada M, Flood EA, Mahmood K, et al
    Development of a stable liquid formulation of live attenuated influenza vaccine.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30239.
    PubMed     Text format     Abstract available


  145. CORACE KM, Srigley JA, Hargadon DP, Yu D, et al
    Using behavior change frameworks to improve healthcare worker influenza vaccination rates: A systematic review.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30236.
    PubMed     Text format     Abstract available


  146. RIZZO C, Bella A, Alfonsi A, Puzelli S, et al
    Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
    Vaccine. 2016 May 4. pii: S0264-410X(16)30237.
    PubMed     Text format     Abstract available


  147. FERNANDEZ-BELLON H, Vergara-Alert J, Almagro V, Rivas R, et al
    Vaccination against H5 avian influenza virus induces long-term humoral immune responses in flamingoes (Phoenicopterus spp.).
    Vaccine. 2016 May 2. pii: S0264-410X(16)30243.
    PubMed     Text format     Abstract available


    April 2016
  148. BENEDICT KM, Kennedy ED, Santibanez TA, Black CL, et al
    Recommendations and offers for adult influenza vaccination, 2011-2012 season, United States.
    Vaccine. 2016 Apr 29. pii: S0264-410X(16)30226.
    PubMed     Text format     Abstract available


  149. HAKIM H, Allison KJ, Van de Velde LA, Tang L, et al
    Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection.
    Vaccine. 2016 Apr 26. pii: S0264-410X(16)30207.
    PubMed     Text format     Abstract available


  150. TRAN CH, Brew J, Johnson N, Ryan KA, et al
    Sustainability of school-located influenza vaccination programs in Florida.
    Vaccine. 2016 Apr 25. pii: S0264-410X(16)30146.
    PubMed     Text format     Abstract available


  151. SANTIBANEZ TA, Kennedy ED
    Reasons given for not receiving an influenza vaccination, 2011-12 influenza season, United States.
    Vaccine. 2016 Apr 23. pii: S0264-410X(16)30191.
    PubMed     Text format     Abstract available


  152. FRASCA D, Diaz A, Romero M, Blomberg BB, et al
    The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations.
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30152.
    PubMed     Text format     Abstract available


  153. NAGY A, Lee J, Mena I, Henningson J, et al
    Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.
    Vaccine. 2016 Apr 18. pii: S0264-410X(16)30151.
    PubMed     Text format     Abstract available


  154. XU L, Bao L, Lau SY, Wu WL, et al
    Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30004.
    PubMed     Text format     Abstract available


  155. WAIBOCI LW, Mott JA, Kikwai G, Arunga G, et al
    Which influenza vaccine formulation should be used in Kenya? A comparison of influenza isolates from Kenya to vaccine strains, 2007-2013.
    Vaccine. 2016 Apr 11. pii: S0264-410X(16)30092.
    PubMed     Text format     Abstract available


  156. LEUNG MK, You JH
    Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly.
    Vaccine. 2016 Apr 11. pii: S0264-410X(16)30128.
    PubMed     Text format     Abstract available


  157. HANITSCH LG, Lobel M, Mieves JF, Bauer S, et al
    Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
    Vaccine. 2016 Apr 4. pii: S0264-410X(16)30088.
    PubMed     Text format     Abstract available


    March 2016
  158. REGAN AK, Tracey LE, Blyth CC, Richmond PC, et al
    A prospective cohort study assessing the reactogenicity of pertussis and influenza vaccines administered during pregnancy.
    Vaccine. 2016 Mar 31. pii: S0264-410X(16)30081.
    PubMed     Text format     Abstract available


  159. BERLANDA SCORZA F, Tsvetnitsky V, Donnelly JJ
    Universal influenza vaccines: Shifting to better vaccines.
    Vaccine. 2016 Mar 30. pii: S0264-410X(16)30082.
    PubMed     Text format     Abstract available


  160. QIN Y, Zhang Y, Wu P, Feng S, et al
    Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15.
    Vaccine. 2016 Mar 26. pii: S0264-410X(16)30064.
    PubMed     Text format     Abstract available


  161. GHERASIM A, Pozo F, de Mateo S, Gamarrad IA, et al
    Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30008.
    PubMed     Text format     Abstract available


  162. WANG Y, Zhang T, Chen L, Greene C, et al
    Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China.
    Vaccine. 2016 Mar 23. pii: S0264-410X(16)30039.
    PubMed     Text format     Abstract available


  163. HABER P, Moro PL, Lewis P, Woo EJ, et al
    Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.
    Vaccine. 2016 Mar 22. pii: S0264-410X(16)30031.
    PubMed     Text format     Abstract available


  164. CHIU SS, Feng S, Chan KH, Lo JY, et al
    Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)30005.
    PubMed     Text format     Abstract available


  165. OU H, Yao H, Yao W, Wu N, et al
    Analysis of the immunogenicity and bioactivities of a split influenza A/H7N9 vaccine mixed with MF59 adjuvant in BALB/c mice.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)30010.
    PubMed     Text format     Abstract available


  166. LOUBET P, Guerrisi C, Turbelin C, Blondel B, et al
    Influenza during pregnancy: Incidence, vaccination coverage and attitudes toward vaccination in the French web-based cohort G-GrippeNet.
    Vaccine. 2016 Mar 21. pii: S0264-410X(16)30007.
    PubMed     Text format     Abstract available


  167. MIZUNO D, Kimoto T, Sakai S, Takahashi E, et al
    Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys.
    Vaccine. 2016 Mar 5. pii: S0264-410X(16)00256.
    PubMed     Text format     Abstract available


    February 2016
  168. TALBOT HK, Nian H, Chen Q, Zhu Y, et al
    Evaluating the case-positive, control test-negative study design for influenza vaccine effectiveness for the frailty bias.
    Vaccine. 2016 Feb 27. pii: S0264-410X(16)00200.
    PubMed     Text format     Abstract available


  169. FENG S, Cowling BJ, Sullivan SG
    Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings.
    Vaccine. 2016 Feb 23. pii: S0264-410X(16)00202.
    PubMed     Text format     Abstract available


  170. FANG R, Lv M, Wu J, Pang X, et al
    The free vaccination policy of influenza in Beijing, China: The vaccine coverage and its associated factors.
    Vaccine. 2016 Feb 22. pii: S0264-410X(16)00174.
    PubMed     Text format     Abstract available


  171. MULLIN J, Ahmed MS, Sharma R, Upile N, et al
    Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines.
    Vaccine. 2016 Feb 19. pii: S0264-410X(16)00170.
    PubMed     Text format     Abstract available


  172. AKAN H, Yavuz E, Yayla E, Kulbay H, et al
    Factors affecting uptake of influenza vaccination among family physicians.
    Vaccine. 2016 Feb 17. pii: S0264-410X(16)00120.
    PubMed     Text format     Abstract available


  173. MOSTERIN HOPPING A, Fonville JM, Russell CA, James S, et al
    Influenza B vaccine lineage selection-An optimized trivalent vaccine.
    Vaccine. 2016 Feb 16. pii: S0264-410X(16)00094.
    PubMed     Text format     Abstract available


  174. THOMPSON MG, Naleway A, Fry AM, Ball S, et al
    Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.
    Vaccine. 2016;34:981-8.
    PubMed     Text format     Abstract available


  175. YAM KK, Gupta J, Allen EK, Burt KR, et al
    Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice.
    Vaccine. 2016 Feb 9. pii: S0264-410X(16)00138.
    PubMed     Text format     Abstract available


  176. KAPCZYNSKI DR, Tumpey TM, Hidajat R, Zsak A, et al
    Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.
    Vaccine. 2016 Feb 8. pii: S0264-410X(16)00137.
    PubMed     Text format     Abstract available


  177. MOROZ E, Albrecht RA, Aden B, Beeder AB, et al
    Active opioid use does not attenuate the humoral responses to inactivated influenza vaccine.
    Vaccine. 2016 Feb 6. pii: S0264-410X(16)00103.
    PubMed     Text format     Abstract available


  178. CASTILLA J, Navascues A, Fernandez-Alonso M, Reina G, et al
    Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00117.
    PubMed     Text format     Abstract available


  179. DITSUNGNOEN D, Greenbaum A, Prapasiri P, Dawood FS, et al
    Knowledge, attitudes and beliefs related to seasonal influenza vaccine among pregnant women in Thailand.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00119.
    PubMed     Text format     Abstract available


  180. CHAMBERLAIN AT, Berkelman RL, Ault KA, Rosenberg ES, et al
    Trends in reasons for non-receipt of influenza vaccination during pregnancy in Georgia, 2004-2011.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00121.
    PubMed     Text format     Abstract available


  181. TUCKERMAN J, Thomas N, Marshall HS
    Should professionals caring for children be vaccinated? Community perspectives on health care and child care worker immunisation.
    Vaccine. 2016 Feb 5. pii: S0264-410X(16)00122.
    PubMed     Text format     Abstract available


  182. ITABORAHY RM, Mancini DA, Medeiros SF
    Response to the influenza vaccine based on estradiol use in menopausal women.
    Vaccine. 2016 Feb 4. pii: S0264-410X(16)00115.
    PubMed     Text format     Abstract available


  183. JANG YH, Jung EJ, Lee KH, Byun YH, et al
    Genetic analysis of attenuation markers of cold-adapted X-31 influenza live vaccine donor strain.
    Vaccine. 2016 Feb 4. pii: S0264-410X(16)00116.
    PubMed     Text format     Abstract available


  184. LEHMANN BA, Chapman GB, Franssen FM, Kok G, et al
    Changing the default to promote influenza vaccination among health care workers.
    Vaccine. 2016 Feb 3. pii: S0264-410X(16)00098.
    PubMed     Text format     Abstract available


  185. SANTIBANEZ TA, Vogt T, Zhai Y, McIntyre A, et al
    Place of influenza vaccination among children-United States, 2010-11 through 2013-14 influenza seasons.
    Vaccine. 2016 Feb 2. pii: S0264-410X(16)00076.
    PubMed     Text format     Abstract available


  186. KHAN TM, Khan AU, Ali I, Chia DW, et al
    Knowledge, attitude and awareness among healthcare professionals about influenza vaccination in Peshawar, Pakistan.
    Vaccine. 2016 Feb 1. pii: S0264-410X(16)00097.
    PubMed     Text format     Abstract available


    January 2016
  187. RAPPAZZO CG, Watkins HC, Guarino CM, Chau A, et al
    Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice.
    Vaccine. 2016 Jan 29. pii: S0264-410X(16)00072.
    PubMed     Text format     Abstract available


  188. TAN HX, Gilbertson BP, Jegaskanda S, Alcantara S, et al
    Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses.
    Vaccine. 2016 Jan 28. pii: S0264-410X(16)00074.
    PubMed     Text format     Abstract available


  189. SAITO S, Ainai A, Suzuki T, Harada N, et al
    The effect of mucoadhesive excipient on the nasal retention time of and the antibody responses induced by an intranasal influenza vaccine.
    Vaccine. 2016 Jan 20. pii: S0264-410X(16)00055.
    PubMed     Text format     Abstract available


  190. ARRIOLA CS, Vasconez N, Thompson M, Mirza S, et al
    Factors associated with a successful expansion of influenza vaccination among pregnant women in Nicaragua.
    Vaccine. 2016 Jan 15. pii: S0264-410X(16)00002.
    PubMed     Text format     Abstract available


  191. NAWA N, Kogaki S, Takahashi K, Ishida H, et al
    Analysis of public concerns about influenza vaccinations by mining a massive online question dataset in Japan.
    Vaccine. 2016 Jan 14. pii: S0264-410X(16)00027.
    PubMed     Text format     Abstract available


  192. LANE CR, Carville KS, Pierse N, Kelly HA, et al
    Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach.
    Vaccine. 2016 Jan 12. pii: S0264-410X(16)00021.
    PubMed     Text format     Abstract available


  193. JIANG J, Fisher EM, Concannon M, Lustigman S, et al
    Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1.
    Vaccine. 2016 Jan 12. pii: S0264-410X(16)00022.
    PubMed     Text format     Abstract available


  194. BATES JT, Pickens JA, Schuster JE, Johnson M, et al
    Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates.
    Vaccine. 2016 Jan 7. pii: S0264-410X(15)01842.
    PubMed     Text format     Abstract available


  195. CAO W, Liepkalns J, Hassan AO, Kamal R, et al
    A highly immunogenic vaccine against A(H7N9) influenza virus.
    Vaccine. 2016 Jan 4. pii: S0264-410X(15)01873.
    PubMed     Text format     Abstract available


  196. ZHANG Y, Qiao L, Hu X, Zhao K, et al
    Baculovirus vectors expressing F proteins in combination with virus-induced signaling adaptor (VISA) molecules confer protection against respiratory syncytial virus infection.
    Vaccine. 2016;34:252-60.
    PubMed     Text format     Abstract available


  197. GARG R, Latimer L, Wang Y, Simko E, et al
    Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs.
    Vaccine. 2016;34:261-9.
    PubMed     Text format     Abstract available


  198. MERCKX J, McCormack D, Quach C
    Improving influenza vaccination in chronically ill children using a tertiary-care based vaccination clinic: Is there a role for the live-attenuated influenza vaccine (LAIV)?
    Vaccine. 2016 Jan 2. pii: S0264-410X(15)01866.
    PubMed     Text format     Abstract available


  199. KRISTENSEN M, van Lier A, Eilers R, McDonald SA, et al
    Burden of four vaccine preventable diseases in older adults.
    Vaccine. 2016 Jan 2. pii: S0264-410X(15)01863.
    PubMed     Text format     Abstract available


    December 2015
  200. HALSEY NA, Talaat KR, Greenbaum A, Mensah E, et al
    The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.
    Vaccine. 2015;33 Suppl 5:F1-F67.
    PubMed     Text format     Abstract available


  201. DETERMANN D, de Bekker-Grob EW, French J, Voeten HA, et al
    Future pandemics and vaccination: Public opinion and attitudes across three European countries.
    Vaccine. 2015 Dec 28. pii: S0264-410X(15)01832.
    PubMed     Text format     Abstract available


  202. ZHANG J, Zhang Z, Fan HY, Zhang J, et al
    Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell-dependent, cross-clade protection against H5N1 influenza virus in mice.
    Vaccine. 2015 Dec 23. pii: S0264-410X(15)01836.
    PubMed     Text format     Abstract available


  203. JAMSHED S, Walsh EE, Dimitroff LJ, Santelli JS, et al
    Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial.
    Vaccine. 2015 Dec 22. pii: S0264-410X(15)01834.
    PubMed     Text format     Abstract available


  204. LUO Z, Ma L, Zhang L, Martin L, et al
    Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.
    Vaccine. 2015 Dec 22. pii: S0264-410X(15)01835.
    PubMed     Text format     Abstract available


  205. TABYNOV K, Yespembetov B, Ryskeldinova S, Zinina N, et al
    Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.
    Vaccine. 2015 Dec 19. pii: S0264-410X(15)01819.
    PubMed     Text format     Abstract available


  206. EICHELBERGER MC, Couzens L, Gao Y, Levine M, et al
    Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicity.
    Vaccine. 2015 Dec 18. pii: S0264-410X(15)01794.
    PubMed     Text format     Abstract available


  207. SALISBURY DM
    Commentary on: "Seasonal influenza vaccine dose distribution in 195 countries (2004-2013): Little progress in estimated global vaccination coverage".
    Vaccine. 2015 Dec 18. pii: S0264-410X(15)01777.
    PubMed     Text format    


  208. CHANG DH, Bednarczyk RA, Becker ER, Hockenberry JM, et al
    Trends in U.S. hospitalizations and inpatient deaths from pneumonia and influenza, 1996-2011.
    Vaccine. 2015 Dec 17. pii: S0264-410X(15)01774.
    PubMed     Text format     Abstract available


  209. KIM JH, Liepkalns J, Reber AJ, Lu X, et al
    Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains.
    Vaccine. 2015 Dec 16. pii: S0264-410X(15)01772.
    PubMed     Text format     Abstract available


  210. PIERSE N, Kelly H, Thompson MG, Bissielo A, et al
    Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014.
    Vaccine. 2015 Dec 9. pii: S0264-410X(15)01767.
    PubMed     Text format     Abstract available


  211. HOPPING AM, McElhaney J, Fonville JM, Powers DC, et al
    The confounded effects of age and exposure history in response to influenza vaccination.
    Vaccine. 2015 Dec 5. pii: S0264-410X(15)01724.
    PubMed     Text format     Abstract available


  212. MBAWUIKE IN, Atmar RL, Patel SM, Corry DB, et al
    Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.
    Vaccine. 2015 Dec 4. pii: S0264-410X(15)01705.
    PubMed     Text format     Abstract available


  213. BROADBENT AJ, Santos CP, Anafu A, Wimmer E, et al
    Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets.
    Vaccine. 2015 Dec 2. pii: S0264-410X(15)01704.
    PubMed     Text format     Abstract available


    November 2015
  214. NAKAMURA K, Shirakura M, Suzuki Y, Naito T, et al
    Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.
    Vaccine. 2015 Nov 30. pii: S0264-410X(15)01700.
    PubMed     Text format     Abstract available


  215. NOLAN T, Chotpitayasunondh T, Capeding MR, Carson S, et al
    Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multi-center, observer-blind study.
    Vaccine. 2015 Nov 28. pii: S0264-410X(15)01682.
    PubMed     Text format     Abstract available


  216. SHI S, Chen S, Han W, Wu B, et al
    Cross-clade protective immune responses of NS1-truncated live attenuated H5N1 avian influenza vaccines.
    Vaccine. 2015 Nov 27. pii: S0264-410X(15)01694.
    PubMed     Text format     Abstract available


  217. THOMAS RE
    The case for ILI surveillance.
    Vaccine. 2015;33:6515-6.
    PubMed     Text format    


  218. PATERSON BJ, Durrheim DN
    The case for ILI surveillance.
    Vaccine. 2015;33:6514.
    PubMed     Text format    


  219. KANDEIL A, Moatasim Y, Gomaa MR, Shehata MM, et al
    Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
    Vaccine. 2015 Nov 24. pii: S0264-410X(15)01679.
    PubMed     Text format     Abstract available


  220. YUEN CY, Dodgson JE, Tarrant M
    Perceptions of Hong Kong Chinese women toward influenza vaccination during pregnancy.
    Vaccine. 2015 Nov 23. pii: S0264-410X(15)01674.
    PubMed     Text format     Abstract available


  221. SU FH, Huang YL, Sung FC, Su CT, et al
    Annual influenza vaccination reduces total hospitalization in patients with chronic hepatitis B virus infection: A population-based analysis.
    Vaccine. 2015 Nov 21. pii: S0264-410X(15)01585.
    PubMed     Text format     Abstract available


  222. COWLING BJ, Feng S, Finelli L, Steffens A, et al
    Assessment of influenza vaccine effectiveness in a sentinel surveillance network 2010-13, United States.
    Vaccine. 2015 Nov 21. pii: S0264-410X(15)01636.
    PubMed     Text format     Abstract available


  223. ESPOSITO S, Giavoli C, Trombetta C, Bianchini S, et al
    Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children.
    Vaccine. 2015 Nov 19. pii: S0264-410X(15)01639.
    PubMed     Text format     Abstract available


  224. WONG VW, Lok KY, Tarrant M
    Interventions to increase the uptake of seasonal influenza vaccination among pregnant women: A systematic review.
    Vaccine. 2015 Nov 18. pii: S0264-410X(15)01640.
    PubMed     Text format     Abstract available


  225. CASPARD H, Gaglani M, Clipper L, Belongia EA, et al
    Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States.
    Vaccine. 2015 Nov 14. pii: S0264-410X(15)01615.
    PubMed     Text format     Abstract available


  226. DEISS RG, Arnold JC, Chen WJ, Echols S, et al
    Vaccine-associated reduction in symptom severity among patients with influenza A/H3N2 disease.
    Vaccine. 2015 Nov 9. pii: S0264-410X(15)01603.
    PubMed     Text format     Abstract available


  227. FERNANDEZ-RUIZ M, Humar A, Baluch A, Keshwani S, et al
    Baseline serum interleukin-6 to interleukin-2 ratio is associated with the response to seasonal trivalent influenza vaccine in solid organ transplant recipients.
    Vaccine. 2015 Nov 7. pii: S0264-410X(15)01596.
    PubMed     Text format     Abstract available


  228. DIAZGRANADOS CA, Saway W, Gouaux J, Baron M, et al
    Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50-64 years of age.
    Vaccine. 2015 Nov 7. pii: S0264-410X(15)01593.
    PubMed     Text format     Abstract available


  229. CHEN Z, Gupta T, Xu P, Phan S, et al
    Efficacy of parainfluenza virus 5 (PIV5)-based tuberculosis vaccines in mice.
    Vaccine. 2015 Nov 6. pii: S0264-410X(15)01580.
    PubMed     Text format     Abstract available


  230. CARIGNAN D, Therien A, Rioux G, Paquet G, et al
    Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine.
    Vaccine. 2015 Nov 5. pii: S0264-410X(15)01579.
    PubMed     Text format     Abstract available


  231. BLYTH CC, Cheng AC, Finucane C, Jacoby P, et al
    The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia.
    Vaccine. 2015 Nov 5. pii: S0264-410X(15)01578.
    PubMed     Text format     Abstract available


  232. BOGAERT K
    Cross protection between the first and second waves of the 1918 influenza pandemic among soldiers of the Canadian Expeditionary Force (CEF) in Ontario.
    Vaccine. 2015 Nov 4. pii: S0264-410X(15)01576.
    PubMed     Text format     Abstract available


    October 2015
  233. COLEMAN BL, McNeil SA, Langley JM, Halperin SA, et al
    Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01551.
    PubMed     Text format     Abstract available


  234. IZIKSON R, Leffell DJ, Bock SA, Patriarca PA, et al
    Randomized comparison of the safety of Flublok versus licensed inactivated influenza vaccine in healthy, medically stable adults >/=50 years of age.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01553.
    PubMed     Text format     Abstract available


  235. CHENG AC, Kotsimbos T, Kelly PM
    Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01431.
    PubMed     Text format     Abstract available


  236. MAUNDER HE, Taylor G, Leppard KN, Easton AJ, et al
    Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice.
    Vaccine. 2015 Oct 31. pii: S0264-410X(15)01561.
    PubMed     Text format     Abstract available


  237. ARAKANE R, Annaka R, Takahama A, Ishida K, et al
    Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A randomized controlled phase III study.
    Vaccine. 2015 Oct 28. pii: S0264-410X(15)01531.
    PubMed     Text format     Abstract available


  238. MORO PL, Winiecki S, Lewis P, Shimabukuro TT, et al
    Surveillance of adverse events after the first trivalent inactivated influenza vaccine produced in mammalian cell culture (Flucelvax) reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015.
    Vaccine. 2015 Oct 27. pii: S0264-410X(15)01527.
    PubMed     Text format     Abstract available


  239. DE FRANCISCO SHAPOVALOVA N, Donadel M, Jit M, Hutubessy R, et al
    A systematic review of the social and economic burden of influenza in low- and middle-income countries.
    Vaccine. 2015 Oct 24. pii: S0264-410X(15)01495.
    PubMed     Text format     Abstract available


  240. REPERANT LA, Grenfell BT, Osterhaus AD
    Quantifying the risk of pandemic influenza virus evolution by mutation and re-assortment.
    Vaccine. 2015 Oct 22. pii: S0264-410X(15)01471.
    PubMed     Text format     Abstract available


  241. KERKHOVE MD, Cooper MJ, Eick-Cost AA, Sanchez JL, et al
    Risk factors for severe outcomes among members of the United States military hospitalized with pneumonia and influenza, 2000-2012.
    Vaccine. 2015 Oct 19. pii: S0264-410X(15)01426.
    PubMed     Text format     Abstract available


  242. MAGNUS P, Gunnes N, Tveito K, Bakken IJ, et al
    Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine.
    Vaccine. 2015 Oct 16. pii: S0264-410X(15)01433.
    PubMed     Text format     Abstract available


  243. COX NJ, Hickling J, Jones R, Rimmelzwaan GF, et al
    Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.
    Vaccine. 2015 Oct 15. pii: S0264-410X(15)01429.
    PubMed     Text format     Abstract available


  244. YANG L, Cowling BJ, Liao Q
    Intention to receive influenza vaccination prior to the summer influenza season in adults of Hong Kong, 2015.
    Vaccine. 2015 Oct 15. pii: S0264-410X(15)01427.
    PubMed     Text format     Abstract available


  245. REGAN AK, Tracey L, Gibbs R
    Post-marketing surveillance of adverse events following immunization with inactivated quadrivalent and trivalent influenza vaccine in health care providers in Western Australia.
    Vaccine. 2015 Oct 14. pii: S0264-410X(15)01416.
    PubMed     Text format     Abstract available


  246. HU W, Sawlwin DC
    Reply to Letter to the Editor.
    Vaccine. 2015;33:5493.
    PubMed     Text format    


  247. ALQAHTANI AS, Alfelali M, Arbon P, Booy R, et al
    Burden of vaccine preventable diseases at large events.
    Vaccine. 2015 Oct 2. pii: S0264-410X(15)01352.
    PubMed     Text format     Abstract available


    September 2015
  248. PILLET S, Racine T, Nfon C, Di Lenardo TZ, et al
    Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
    Vaccine. 2015 Sep 30. pii: S0264-410X(15)01341.
    PubMed     Text format     Abstract available


  249. KISELEVA I, Dubrovina I, Fedorova E, Larionova N, et al
    Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
    Vaccine. 2015 Sep 30. pii: S0264-410X(15)01326.
    PubMed     Text format     Abstract available


  250. ARAKANE R, Nakatani H, Fujisaki E, Takahama A, et al
    Immunogenicity and safety of the new intradermal influenza vaccine in adults and elderly: A randomized phase 1/2 clinical trial.
    Vaccine. 2015 Sep 30. pii: S0264-410X(15)01256.
    PubMed     Text format     Abstract available


  251. RUDENKO L, Sellwood C, Russell C, Herfst S, et al
    Will there ever be a new influenza pandemic and are we prepared?
    Vaccine. 2015 Sep 25. pii: S0264-410X(15)01172.
    PubMed     Text format    


  252. KIM H, Velkov T, Camuglia S, Rockman SP, et al
    Cold adaptation generates mutations associated with the growth of influenza B vaccine viruses.
    Vaccine. 2015 Sep 25. pii: S0264-410X(15)01314.
    PubMed     Text format     Abstract available


  253. NARUSE T, Fukuda T, Tanabe T, Ichikawa M, et al
    A clinical phase I study of an EB66 cell-derived H5N1 pandemic vaccine adjuvanted with AS03.
    Vaccine. 2015 Sep 23. pii: S0264-410X(15)01286.
    PubMed     Text format     Abstract available


  254. WIBOWO N, Wu Y, Fan Y, Meers J, et al
    Non-chromatographic preparation of a bacterially produced single-shot modular virus-like particle capsomere vaccine for avian influenza.
    Vaccine. 2015 Sep 22. pii: S0264-410X(15)01304.
    PubMed     Text format     Abstract available


  255. SPINNER JL, Oberoi HS, Yorgensen YM, Poirier DS, et al
    Methylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.
    Vaccine. 2015 Sep 18. pii: S0264-410X(15)01239.
    PubMed     Text format     Abstract available


  256. DELABRE RM, Salez N, Lemaitre M, Leruez-Ville M, et al
    Antibody persistence and serological protection among seasonal 2007 influenza A(H1N1) infected subjects: Results from the FLUREC cohort study.
    Vaccine. 2015 Sep 17. pii: S0264-410X(15)01274.
    PubMed     Text format     Abstract available


  257. BARANOWSKA M, Hauge AG, Hoornaert C, Bogen B, et al
    Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8-mediated cross protection against influenza.
    Vaccine. 2015 Sep 17. pii: S0264-410X(15)01276.
    PubMed     Text format     Abstract available


  258. VEIT M, Siche S
    S-acylation of influenza virus proteins: Are enzymes for fatty acid attachment promising drug targets?
    Vaccine. 2015 Sep 17. pii: S0264-410X(15)01277.
    PubMed     Text format     Abstract available


  259. KOBBE R
    The ESPID/ESWI Joint Symposium-A strong vote for universal influenza vaccination in children in Europe.
    Vaccine. 2015 Sep 16. pii: S0264-410X(15)01279.
    PubMed     Text format     Abstract available


  260. ZIVKOVIC I, Bufan B, Petrusic V, Minic R, et al
    Sexual diergism in antibody response to whole virus trivalent inactivated influenza vaccine in outbred mice.
    Vaccine. 2015 Sep 14. pii: S0264-410X(15)01249.
    PubMed     Text format     Abstract available


  261. PALACHE A, Oriol-Mathieu V, Fino M, Xydia-Charmanta M, et al
    Seasonal influenza vaccine dose distribution in 195 countries (2004-2013): Little progress in estimated global vaccination coverage.
    Vaccine. 2015 Sep 11. pii: S0264-410X(15)01235.
    PubMed     Text format     Abstract available


  262. RYSER AJ, Heininger U
    Comparative acceptance of pertussis and influenza immunization among health-care personnel.
    Vaccine. 2015 Sep 9. pii: S0264-410X(15)01231.
    PubMed     Text format     Abstract available


  263. RIMMELZWAAN G, Leroux-Roels I, Gilbert S, Thomson A, et al
    Influenza vaccines: Where do we stand? Where do we go?: A bumpy but steady road upwards.
    Vaccine. 2015 Sep 5. pii: S0264-410X(15)01036.
    PubMed     Text format    


  264. WEN Y, Han L, Palladino G, Ferrari A, et al
    Conformationally selective biophysical assay for influenza vaccine potency determination.
    Vaccine. 2015 Sep 5. pii: S0264-410X(15)01230.
    PubMed     Text format     Abstract available


  265. WIKRAMARATNA PS, Rambaut A
    Relationship between haemagglutination inhibition titre and immunity to influenza in ferrets.
    Vaccine. 2015 Sep 2. pii: S0264-410X(15)01193.
    PubMed     Text format     Abstract available


  266. TREANOR JJ
    Prospects for broadly protective influenza vaccines.
    Vaccine. 2015 Sep 1. pii: S0264-410X(15)01181.
    PubMed     Text format     Abstract available


    August 2015
  267. BLANCO JC, Pletneva LM, Oue RO, Patel MC, et al
    Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy.
    Vaccine. 2015 Aug 31. pii: S0264-410X(15)01209.
    PubMed     Text format     Abstract available


  268. BOIRON K, Sarazin M, Debin M, Raude J, et al
    Opinion about seasonal influenza vaccination among the general population 3 years after the A(H1N1)pdm2009 influenza pandemic.
    Vaccine. 2015 Aug 28. pii: S0264-410X(15)01205.
    PubMed     Text format     Abstract available


  269. LAMBACH P, Alvarez AM, Hirve S, Ortiz JR, et al
    Considerations of strategies to provide influenza vaccine year round.
    Vaccine. 2015 Aug 28. pii: S0264-410X(15)01164.
    PubMed     Text format     Abstract available


  270. LAMBACH P, Hombach J, Ortiz JR
    A global perspective of maternal influenza immunization.
    Vaccine. 2015 Aug 28. pii: S0264-410X(15)01163.
    PubMed     Text format    


  271. NGUYEN-VAN-TAM J, Gross D, Sturkenboom M, Parrish-Sprowl J, et al
    Influenza vaccines really work? Keeping apart the true from the false.
    Vaccine. 2015 Aug 28. pii: S0264-410X(15)01180.
    PubMed     Text format    


  272. JIT M, Brewer N, McKenzie D, Odugleh-Kolev A, et al
    Building a new communication paradigm: Can we influence influenza perception?
    Vaccine. 2015 Aug 28. pii: S0264-410X(15)01178.
    PubMed     Text format    


  273. SAVITZ DA, Fell DB, Ortiz JR, Bhat N, et al
    Does influenza vaccination improve pregnancy outcome? Methodological issues and research needs.
    Vaccine. 2015 Aug 26. pii: S0264-410X(15)01168.
    PubMed     Text format     Abstract available


  274. WIERSMA LC, Vogelzang-van Trierum SE, Kreijtz JH, van Amerongen G, et al
    Heterosubtypic immunity to H7N9 influenza virus in isogenic guinea pigs after infection with pandemic H1N1 virus.
    Vaccine. 2015 Aug 25. pii: S0264-410X(15)01165.
    PubMed     Text format     Abstract available


  275. HOFFMANN J, Otte A, Thiele S, Lotter H, et al
    Sex differences in H7N9 influenza A virus pathogenesis.
    Vaccine. 2015 Aug 25. pii: S0264-410X(15)01171.
    PubMed     Text format     Abstract available


  276. OSTERHAUS A, Brooks A, Broberg E, MacIntyre R, et al
    Why should influenza be a public health priority?
    Vaccine. 2015 Aug 25. pii: S0264-410X(15)01176.
    PubMed     Text format     Abstract available


  277. THORRINGTON D, Jit M, Eames K
    Targeted vaccination in healthy school children - Can primary school vaccination alone control influenza?
    Vaccine. 2015 Aug 24. pii: S0264-410X(15)01157.
    PubMed     Text format     Abstract available


  278. SONG JY, Cheong HJ, Lee J, Woo HJ, et al
    Immunogenicity and safety of a cell culture-derived inactivated trivalent influenza vaccine (NBP607): A randomized, double-blind, multi-center, phase 3 clinical trial.
    Vaccine. 2015 Aug 24. pii: S0264-410X(15)01156.
    PubMed     Text format     Abstract available


  279. WIERSMA LC, Kreijtz JH, Vogelzang-van Trierum SE, van Amerongen G, et al
    Virus replication kinetics and pathogenesis of infection with H7N9 influenza virus in isogenic guinea pigs upon intratracheal inoculation.
    Vaccine. 2015 Aug 22. pii: S0264-410X(15)01177.
    PubMed     Text format     Abstract available


  280. RUDENKO L, Kiseleva I, Stukova M, Erofeeva M, et al
    Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: Results from a placebo-controlled, randomized double-blind phase I study.
    Vaccine. 2015 Aug 19. pii: S0264-410X(15)01133.
    PubMed     Text format     Abstract available


  281. RODGERS L, Pabst LJ, Zhu L, Chaves SS, et al
    Usage of quadrivalent influenza vaccine among children in the United States, 2013-14.
    Vaccine. 2015 Aug 19. pii: S0264-410X(15)01132.
    PubMed     Text format     Abstract available


  282. ASGHAR Z, Coupland C, Siriwardena N
    Influenza vaccination and risk of stroke: Self-controlled case-series study.
    Vaccine. 2015 Aug 18. pii: S0264-410X(15)01127.
    PubMed     Text format     Abstract available


  283. KHAN AA, Varan AK, Esteves-Jaramillo A, Siddiqui M, et al
    Influenza vaccine acceptance among pregnant women in urban slum areas, Karachi, Pakistan.
    Vaccine. 2015 Aug 18. pii: S0264-410X(15)01128.
    PubMed     Text format     Abstract available


  284. WANG Z, Chua BY, Ramos JV, Parra SQ, et al
    Establishment of functional influenza virus-specific CD8 T cell memory pools after intramuscular immunization.
    Vaccine. 2015 Aug 12. pii: S0264-410X(15)01109.
    PubMed     Text format     Abstract available


  285. ROWLEN K
    Validation of alternative potency assays for influenza vaccines requires clinical studies.
    Vaccine. 2015 Aug 12. pii: S0264-410X(15)01021.
    PubMed     Text format     Abstract available


  286. MANCEUR AP, Kamen AA
    Critical review of current and emerging quantification methods for the development of influenza vaccine candidates.
    Vaccine. 2015 Aug 10. pii: S0264-410X(15)01108.
    PubMed     Text format     Abstract available


  287. KINGSTAD-BAKKE B, Kamlangdee A, Osorio JE
    Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge.
    Vaccine. 2015 Aug 10. pii: S0264-410X(15)01115.
    PubMed     Text format     Abstract available


  288. JACKSON ML, Jackson LA, Kieke B, McClure D, et al
    Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons.
    Vaccine. 2015 Aug 10. pii: S0264-410X(15)01102.
    PubMed     Text format     Abstract available


  289. VAN ESSEN GE, Openshaw P, Myles P, Monto A, et al
    How should influenza be treated? Focus on antivirals.
    Vaccine. 2015 Aug 6. pii: S0264-410X(15)01033.
    PubMed     Text format    


  290. KIM WJ, Lee SD, Lee E, Namkoong K, et al
    Incidence of narcolepsy before and after MF59-adjuvanted influenza A(H1N1)pdm09 vaccination in South Korean soldiers.
    Vaccine. 2015 Aug 1. pii: S0264-410X(15)01016.
    PubMed     Text format     Abstract available


  291. CURTIS D, Ning MF, Armon C, Li S, et al
    Safety, immunogenicity and shedding of LAIV4 in HIV-infected and uninfected children.
    Vaccine. 2015 Aug 1. pii: S0264-410X(15)01060.
    PubMed     Text format     Abstract available


    July 2015
  292. KAHN KE, Santibanez TA, Zhai Y, Singleton JA, et al
    Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons.
    Vaccine. 2015 Jul 31. pii: S0264-410X(15)01025.
    PubMed     Text format     Abstract available


  293. BAUM U, Leino T, Gissler M, Kilpi T, et al
    Perinatal survival and health after maternal influenza A(H1N1)pdm09 vaccination: A cohort study of pregnancies stratified by trimester of vaccination.
    Vaccine. 2015 Jul 31. pii: S0264-410X(15)01022.
    PubMed     Text format     Abstract available


  294. BARJESTEH N, Shojadoost B, Brisbin JT, Emam M, et al
    Reduction of avian influenza virus shedding by administration of Toll-like receptor ligands to chickens.
    Vaccine. 2015 Jul 31. pii: S0264-410X(15)01039.
    PubMed     Text format     Abstract available


  295. KWONG JC, Pereira JA, Quach S, Pellizzari R, et al
    Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) cluster randomized trial: Pilot results from a household surveillance study to assess direct and indirect protection from influenza vaccination.
    Vaccine. 2015 Jul 29. pii: S0264-410X(15)01004.
    PubMed     Text format     Abstract available


  296. CHAWANSUNTATI K, Aurpibul L, Wipasa J
    Vaccination for 2009 pandemic H1N1 influenza A did not induce conserved epitope-specific memory CD8 T cell responses in HIV+ northern Thai children.
    Vaccine. 2015 Jul 29. pii: S0264-410X(15)01009.
    PubMed     Text format     Abstract available


  297. TACKEN MA, Jansen B, Mulder J, Campbell SM, et al
    Dutch influenza vaccination rate drops for fifth consecutive year.
    Vaccine. 2015 Jul 29. pii: S0264-410X(15)01013.
    PubMed     Text format     Abstract available


  298. HONDA-OKUBO Y, Ong CH, Petrovsky N
    Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protection.
    Vaccine. 2015 Jul 28. pii: S0264-410X(15)01012.
    PubMed     Text format     Abstract available


  299. CHAN EY, Cheng CK, Tam G, Huang Z, et al
    Willingness of future A/H7N9 influenza vaccine uptake: A cross-sectional study of Hong Kong community.
    Vaccine. 2015 Jul 27. pii: S0264-410X(15)01006.
    PubMed     Text format     Abstract available


  300. DIAZGRANADOS CA, Robertson CA, Talbot HK, Landolfi V, et al
    Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines.
    Vaccine. 2015 Jul 26. pii: S0264-410X(15)00934.
    PubMed     Text format     Abstract available


  301. DE SERRES G, Rouleau I, Skowronski DM, Ouakki M, et al
    Paresthesia and sensory disturbances associated with 2009 pandemic vaccine receipt: Clinical features and risk factors.
    Vaccine. 2015 Jul 22. pii: S0264-410X(15)00972.
    PubMed     Text format     Abstract available


  302. PUSHKO P, Pujanauski LM, Sun X, Pearce M, et al
    Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.
    Vaccine. 2015 Jul 21. pii: S0264-410X(15)00970.
    PubMed     Text format     Abstract available


  303. MEDINA J, Boukhebza H, De Saint Jean A, Sodoyer R, et al
    Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
    Vaccine. 2015 Jul 20. pii: S0264-410X(15)00981.
    PubMed     Text format     Abstract available


  304. LAVELA SL, Etingen B, Miskevics S
    Attitudes toward influenza vaccination improvement strategies in Veterans Affairs health care workers providing care for patients with spinal cord injuries and disorders: Acceptability of a declination form program.
    Vaccine. 2015 Jul 18. pii: S0264-410X(15)00898.
    PubMed     Text format     Abstract available


  305. KOUL PA, Bali NK
    Influenza vaccination in India: Challenges for universal adoption.
    Vaccine. 2015 Jul 18. pii: S0264-410X(15)00965.
    PubMed     Text format    


  306. FISCHER WA 2ND, King LS, Lane AP, Pekosz A, et al
    Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells.
    Vaccine. 2015 Jul 18. pii: S0264-410X(15)00967.
    PubMed     Text format     Abstract available


  307. OSTERHAUS AD, Vanlangendonck C
    Proceedings Fifth ESWI Influenza Conference.
    Vaccine. 2015 Jul 17. pii: S0264-410X(15)00925.
    PubMed     Text format    


  308. NAKAYAMA T, Kumagai T, Nishimura N, Ozaki T, et al
    Seasonal split influenza vaccine induced IgE sensitization against influenza vaccine.
    Vaccine. 2015 Jul 15. pii: S0264-410X(15)00912.
    PubMed     Text format     Abstract available


  309. DIAZGRANADOS CA, Dunning AJ, Robertson CA, Talbot HK, et al
    Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty.
    Vaccine. 2015 Jul 14. pii: S0264-410X(15)00927.
    PubMed     Text format     Abstract available


  310. AMPOFO WK, Azziz-Baumgartner E, Bashir U, Cox NJ, et al
    Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
    Vaccine. 2015 Jul 3. pii: S0264-410X(15)00905.
    PubMed     Text format     Abstract available


  311. ALHAMMADI A, Khalifa M, Abdulrahman H, Almuslemani E, et al
    Attitudes and perceptions among the pediatric health care providers toward influenza vaccination in Qatar: A cross-sectional study.
    Vaccine. 2015 Jul 2. pii: S0264-410X(15)00897.
    PubMed     Text format     Abstract available


  312. ARRIOLA CS, Mercado-Crespo MC, Rivera B, Serrano-Rodriguez R, et al
    Reasons for low influenza vaccination coverage among adults in Puerto Rico, influenza season 2013-2014.
    Vaccine. 2015 Jul 2. pii: S0264-410X(15)00908.
    PubMed     Text format     Abstract available


  313. KHIEU TQ, Pierse N, Barnard LF, Huang QS, et al
    Estimating the contribution of influenza to hospitalisations in New Zealand from 1994 to 2008.
    Vaccine. 2015 Jul 1. pii: S0264-410X(15)00895.
    PubMed     Text format     Abstract available


    June 2015
  314. ZANG Y, Du D, Li N, Su W, et al
    Eliciting neutralizing antibodies against the membrane proximal external region of HIV-1 Env by chimeric live attenuated influenza A virus vaccines.
    Vaccine. 2015 Jun 27. pii: S0264-410X(15)00873.
    PubMed     Text format     Abstract available


  315. EFFLER PV, Kelly HA
    bioCSL Limited's 2009 clinical trial to assess the immunogenicity and safety of trivalent influenza vaccine in US children raises concern.
    Vaccine. 2015 Jun 25. pii: S0264-410X(15)00641.
    PubMed     Text format    


  316. BURGESS TH, Murray CK, Bavaro MF, Landrum ML, et al
    Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptance.
    Vaccine. 2015 Jun 25. pii: S0264-410X(15)00862.
    PubMed     Text format     Abstract available


  317. GENTILE A, Juarez M, Hernandez S, Moya A, et al
    Influenza vaccine: Delayed vaccination schedules and missed opportunities in children under 2 years old.
    Vaccine. 2015 Jun 24. pii: S0264-410X(15)00866.
    PubMed     Text format     Abstract available


  318. MURAKAMI K, Matsuura M, Ota M, Gomi Y, et al
    A recombinant varicella vaccine harboring a respiratory syncytial virus gene induces humoral immunity.
    Vaccine. 2015 Jun 23. pii: S0264-410X(15)00611.
    PubMed     Text format     Abstract available


  319. LIU Q, Xue C, Zheng J, Liu K, et al
    Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice.
    Vaccine. 2015 Jun 19. pii: S0264-410X(15)00696.
    PubMed     Text format     Abstract available


  320. MODJARRAD K, Giersing B, Kaslow DC, Smith PG, et al
    WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.
    Vaccine. 2015 Jun 19. pii: S0264-410X(15)00767.
    PubMed     Text format     Abstract available


  321. OMER SB, Richards JL, Madhi SA, Tapia MD, et al
    Three randomized trials of maternal influenza immunization in Mali, Nepal, and South Africa: Methods and expectations.
    Vaccine. 2015 Jun 18. pii: S0264-410X(15)00750.
    PubMed     Text format     Abstract available


  322. CHUNG KY, Coyle EM, Jani D, King LR, et al
    ISCOMATRIX adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.
    Vaccine. 2015 Jun 17. pii: S0264-410X(15)00836.
    PubMed     Text format     Abstract available


  323. TABYNOV K, Ryskeldinova S, Sansyzbay A
    An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers.
    Vaccine. 2015 Jun 17. pii: S0264-410X(15)00834.
    PubMed     Text format     Abstract available


  324. SINGH SM, Alkie TN, Hodgins DC, Nagy E, et al
    Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens.
    Vaccine. 2015 Jun 16. pii: S0264-410X(15)00832.
    PubMed     Text format     Abstract available


  325. PYO HM, Hlasny M, Zhou Y
    Influence of maternally-derived antibodies on live attenuated influenza vaccine efficacy in pigs.
    Vaccine. 2015 Jun 16. pii: S0264-410X(15)00833.
    PubMed     Text format     Abstract available


  326. KENNEDY RB, Tosh PK, Goergen KM, Grill DE, et al
    Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults.
    Vaccine. 2015 Jun 15. pii: S0264-410X(15)00820.
    PubMed     Text format     Abstract available


  327. TANAKA S, Saikusa T, Katafuchi Y, Ushijima K, et al
    Serologic response after vaccination against influenza (A/H1N1)pdm09 in children with renal disease receiving oral immunosuppressive drugs.
    Vaccine. 2015 Jun 14. pii: S0264-410X(15)00838.
    PubMed     Text format     Abstract available


  328. LOUBET P, Kerneis S, Groh M, Loulergue P, et al
    Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
    Vaccine. 2015 Jun 11. pii: S0264-410X(15)00785.
    PubMed     Text format     Abstract available


  329. BERTRAN K, Thomas C, Guo X, Bublot M, et al
    Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens.
    Vaccine. 2015 Jun 9. pii: S0264-410X(15)00749.
    PubMed     Text format     Abstract available


  330. STURKENBOOM MC
    The narcolepsy-pandemic influenza story: Can the truth ever be unraveled?
    Vaccine. 2015;33 Suppl 2:B6-B13.
    PubMed     Text format     Abstract available


  331. BLACK S
    Safety and effectiveness of MF-59 adjuvanted influenza vaccines in children and adults.
    Vaccine. 2015;33 Suppl 2:B3-B5.
    PubMed     Text format     Abstract available


  332. ZENG W, Tan AC, Horrocks K, Jackson DC, et al
    A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate.
    Vaccine. 2015 Jun 3. pii: S0264-410X(15)00716.
    PubMed     Text format     Abstract available


  333. RAMEZANPOUR B, Pronker ES, Kreijtz JH, Osterhaus AD, et al
    Market implementation of the MVA platform for pre-pandemic and pandemic influenza vaccines: A quantitative key opinion leader analysis.
    Vaccine. 2015 Jun 2. pii: S0264-410X(15)00572.
    PubMed     Text format     Abstract available


  334. WU AM, Lau JT, Ma YL, Lau MM, et al
    Prevalence and associated factors of seasonal influenza vaccination among 24- to 59-month-old children in Hong Kong.
    Vaccine. 2015 Jun 1. pii: S0264-410X(15)00691.
    PubMed     Text format     Abstract available


  335. BAKER SF, Nogales A, Santiago FW, Topham DJ, et al
    Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).
    Vaccine. 2015 Jun 1. pii: S0264-410X(15)00701.
    PubMed     Text format     Abstract available


  336. CHAMBERLAIN AT, Seib K, Ault KA, Rosenberg ES, et al
    Improving influenza and Tdap vaccination during pregnancy: A cluster-randomized trial of a multi-component antenatal vaccine promotion package in late influenza season.
    Vaccine. 2015 Jun 1. pii: S0264-410X(15)00700.
    PubMed     Text format     Abstract available


  337. ACHTYMICHUK KA, Johnson JA, Al Sayah F, Eurich DT, et al
    Characteristics and health behaviors of diabetic patients receiving influenza vaccination.
    Vaccine. 2015 Jun 1. pii: S0264-410X(15)00699.
    PubMed     Text format     Abstract available


  338. OKADA C, Fujieda M, Fukushima W, Ohfuji S, et al
    Reactogenicity of trivalent inactivated influenza vaccine in young children: Pronounced reactions by previous successive vaccinations.
    Vaccine. 2015 Jun 1. pii: S0264-410X(15)00692.
    PubMed     Text format     Abstract available


  339. SHERIDAN PA, Paich HA, Handy J, Karlsson EA, et al
    The antibody response to influenza vaccination is not impaired in type 2 diabetics.
    Vaccine. 2015 Jun 1. pii: S0264-410X(15)00695.
    PubMed     Text format     Abstract available


    May 2015
  340. MENG Q, Liu G, Liu Y, Deng X, et al
    A broad protection provided by matrix protein 2 (M2) of avian influenza virus.
    Vaccine. 2015 May 30. pii: S0264-410X(15)00697.
    PubMed     Text format     Abstract available


  341. DYDA A, MacIntyre CR, McIntyre P, Newall AT, et al
    Factors associated with influenza vaccination in middle and older aged Australian adults according to eligibility for the national vaccination program.
    Vaccine. 2015 May 30. pii: S0264-410X(15)00698.
    PubMed     Text format     Abstract available


  342. CHRISTIAN LM, Porter K, Karlsson E, Schultz-Cherry S, et al
    Proinflammatory cytokine responses correspond with subjective side effects after influenza virus vaccination.
    Vaccine. 2015 May 28. pii: S0264-410X(15)00622.
    PubMed     Text format     Abstract available


  343. WOHLBOLD TJ, Nachbagauer R, Margine I, Tan GS, et al
    Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.
    Vaccine. 2015 May 27. pii: S0264-410X(15)00690.
    PubMed     Text format     Abstract available


  344. MARTIN ARIAS LH, Sanz R, Sainz M, Treceno C, et al
    Guillain-Barre syndrome and influenza vaccines: A meta-analysis.
    Vaccine. 2015 May 18. pii: S0264-410X(15)00634.
    PubMed     Text format     Abstract available


  345. SONG JY, Cheong HJ, Tsai TF, Chang HA, et al
    Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults.
    Vaccine. 2015 May 14. pii: S0264-410X(15)00617.
    PubMed     Text format     Abstract available


  346. SRIVASTAV A, Zhai Y, Santibanez TA, Kahn KE, et al
    Influenza vaccination coverage of Vaccine for Children (VFC)-entitled versus privately insured children, United States, 2011-2013.
    Vaccine. 2015 May 12. pii: S0264-410X(15)00595.
    PubMed     Text format     Abstract available


  347. TSYBALOVA LM, Stepanova LA, Kuprianov VV, Blokhina EA, et al
    Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
    Vaccine. 2015 May 11. pii: S0264-410X(15)00549.
    PubMed     Text format     Abstract available


  348. CLARKE MS, Benn CS
    Unusual positive effects from vaccines need to be reported - They represent a resource that could lead to new treatment strategies.
    Vaccine. 2015 May 1. pii: S0264-410X(15)00552.
    PubMed     Text format    


    April 2015
  349. RAVIN NV, Blokhina EA, Kuprianov VV, Stepanova LA, et al
    Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant loop region of hepatitis B core antigen: Insertion of multiple copies of M2e increases immunogenicity and protective ef
    Vaccine. 2015 Apr 29. pii: S0264-410X(15)00542.
    PubMed     Text format     Abstract available


  350. NOWAK GJ, Sheedy K, Bursey K, Smith TM, et al
    Promoting influenza vaccination: Insights from a qualitative meta-analysis of 14 years of influenza-related communications research by U.S. Centers for Disease Control and Prevention (CDC).
    Vaccine. 2015 Apr 28. pii: S0264-410X(15)00528.
    PubMed     Text format     Abstract available


  351. VALENCIANO M, Kissling E, Reuss A, Jimenez-Jorge S, et al
    The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Vaccine. 2015 Apr 28. pii: S0264-410X(15)00465.
    PubMed     Text format     Abstract available


  352. GALLIHER-BECKLEY A, Pappan LK, Madera R, Burakova Y, et al
    Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines.
    Vaccine. 2015 Apr 28. pii: S0264-410X(15)00541.
    PubMed     Text format     Abstract available


  353. BONIFICIO A, Ghartey-Tagoe E, Gallorini S, Baudner B, et al
    Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs.
    Vaccine. 2015 Apr 27. pii: S0264-410X(15)00523.
    PubMed     Text format     Abstract available


  354. FU C, Xu J, Lin J, Wang M, et al
    Concurrent and cross-season protection of inactivated influenza vaccine against A(H1N1)pdm09 illness among young children: 2012-2013 case-control evaluation of influenza vaccine effectiveness.
    Vaccine. 2015 Apr 25. pii: S0264-410X(15)00527.
    PubMed     Text format     Abstract available


  355. ORTIZ J, Goswami D, Lewis KD, Sharmeen AT, et al
    Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh.
    Vaccine. 2015 Apr 24. pii: S0264-410X(15)00512.
    PubMed     Text format     Abstract available


  356. IZURIETA P, Kim WJ, Wie SH, Lee J, et al
    Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: A phase IV, randomized, open-label, controlled study.
    Vaccine. 2015 Apr 21. pii: S0264-410X(15)00480.
    PubMed     Text format     Abstract available


  357. YOO BK, Hasebe T, Szilagyi PG
    Decomposing racial/ethnic disparities in influenza vaccination among the elderly.
    Vaccine. 2015 Apr 18. pii: S0264-410X(15)00362.
    PubMed     Text format     Abstract available


  358. ALFELALI M, Barasheed O, Tashani M, Azeem MI, et al
    Changes in the prevalence of influenza-like illness and influenza vaccine uptake among Hajj pilgrims: A 10-year retrospective analysis of data.
    Vaccine. 2015 Apr 14. pii: S0264-410X(15)00459.
    PubMed     Text format     Abstract available


  359. JIMENEZ-JORGE S, Pozo F, Larrauri A, de Mateo S, et al
    Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the last four seasons 2010-2014.
    Vaccine. 2015 Apr 10. pii: S0264-410X(15)00359.
    PubMed     Text format     Abstract available


  360. ORTQVIST A, Bennet R, Hamrin J, Rinder MR, et al
    Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Vaccine. 2015 Apr 10. pii: S0264-410X(15)00464.
    PubMed     Text format     Abstract available


  361. DUBOV A, Phung C
    Nudges or mandates? The ethics of mandatory flu vaccination.
    Vaccine. 2015 Apr 10. pii: S0264-410X(15)00356.
    PubMed     Text format     Abstract available


  362. NYIRO JU, Sande C, Mutunga M, Kiyuka PK, et al
    Quantifying maternally derived respiratory syncytial virus specific neutralising antibodies in a birth cohort from coastal Kenya.
    Vaccine. 2015;33:1797-801.
    PubMed     Text format     Abstract available


  363. LAI CH, Tang N, Jan JT, Huang MH, et al
    Use of recombinant flagellin in oil-in-water emulsions enhances hemagglutinin-specific mucosal IgA production and IL-17 secreting T cells against H5N1 avian influenza virus infection.
    Vaccine. 2015 Apr 6. pii: S0264-410X(15)00401.
    PubMed     Text format     Abstract available


  364. GANY F, Rau-Murthy R, Mujawar I
    Increasing influenza vaccination in New York City taxi drivers: A community driven approach.
    Vaccine. 2015 Apr 4. pii: S0264-410X(15)00326.
    PubMed     Text format     Abstract available


  365. CADORNA-CARLOS JB, Nolan T, Borja-Tabora CF, Santos J, et al
    Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial.
    Vaccine. 2015 Apr 2. pii: S0264-410X(15)00384.
    PubMed     Text format     Abstract available


  366. TAO W, Gill HS
    M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection.
    Vaccine. 2015 Apr 1. pii: S0264-410X(15)00382.
    PubMed     Text format     Abstract available


  367. JACOBY E, Jarrahian C, Hull HF, Zehrung D, et al
    Opportunities and challenges in delivering influenza vaccine by microneedle patch.
    Vaccine. 2015 Apr 1. pii: S0264-410X(15)00381.
    PubMed     Text format     Abstract available


    March 2015
  368. GREEN HK, Andrews N, Letley L, Sunderland A, et al
    Phased introduction of a universal childhood influenza vaccination programme in England: Population-level factors predicting variation in national uptake during the first year, 2013-14.
    Vaccine. 2015 Mar 30. pii: S0264-410X(15)00357.
    PubMed     Text format     Abstract available


  369. RAHN J, Hoffmann D, Harder TC, Beer M, et al
    Vaccines against influenza A viruses in poultry and swine: Status and future developments.
    Vaccine. 2015 Mar 30. pii: S0264-410X(15)00360.
    PubMed     Text format     Abstract available


  370. SMITH M, Peacock G, Uyeki TM, Moore C, et al
    Influenza vaccination in children with neurologic or neurodevelopmental disorders.
    Vaccine. 2015 Mar 30. pii: S0264-410X(15)00358.
    PubMed     Text format     Abstract available


  371. MARCU A, Rubinstein H, Michie S, Yardley L, et al
    Accounting for personal and professional choices for pandemic influenza vaccination amongst English healthcare workers.
    Vaccine. 2015 Mar 25. pii: S0264-410X(15)00327.
    PubMed     Text format     Abstract available


  372. FABIANI M, Bella A, Rota MC, Clagnan E, et al
    A/H1N1 pandemic influenza vaccination: A retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy.
    Vaccine. 2015 Mar 25. pii: S0264-410X(15)00340.
    PubMed     Text format     Abstract available


  373. FOPPA IM, Cheng PY, Reynolds SB, Shay DK, et al
    Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.
    Vaccine. 2015 Mar 23. pii: S0264-410X(15)00231.
    PubMed     Text format     Abstract available


  374. DE VLEESCHAUWER A, Qiu Y, Van Reeth K
    Vaccination-challenge studies with a Port Chalmers/73 (H3N2)-based swine influenza virus vaccine: Reflections on vaccine strain updates and on the vaccine potency test.
    Vaccine. 2015 Mar 21. pii: S0264-410X(15)00330.
    PubMed     Text format     Abstract available


  375. VAN BALVEREN-SLINGERLAND L, Kant A, Harmark L
    Web-based intensive monitoring of adverse events following influenza vaccination in general practice.
    Vaccine. 2015 Mar 19. pii: S0264-410X(15)00302.
    PubMed     Text format    


  376. LAENEN J, Roelants M, Devlieger R, Vandermeulen C, et al
    Influenza and pertussis vaccination coverage in pregnant women.
    Vaccine. 2015 Mar 18. pii: S0264-410X(15)00308.
    PubMed     Text format     Abstract available


  377. MCDADE TW, Borja JB, Kuzawa CW, Perez TL, et al
    C-reactive protein response to influenza vaccination as a model of mild inflammatory stimulation in the Philippines.
    Vaccine. 2015 Mar 18. pii: S0264-410X(15)00307.
    PubMed     Text format     Abstract available


  378. LEE BY, Bartsch SM, Mvundura M, Jarrahian C, et al
    An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine.
    Vaccine. 2015 Mar 12. pii: S0264-410X(15)00288.
    PubMed     Text format     Abstract available


  379. LIU YV, Massare MJ, Pearce MB, Sun X, et al
    Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
    Vaccine. 2015 Mar 12. pii: S0264-410X(15)00297.
    PubMed     Text format     Abstract available


  380. GARG R, Latimer L, Gerdts V, Potter A, et al
    The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies.
    Vaccine. 2015;33:1338-44.
    PubMed     Text format     Abstract available


  381. MCMILLAN M, Porritt K, Kralik D, Costi L, et al
    Influenza vaccination during pregnancy: A systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes.
    Vaccine. 2015 Mar 7. pii: S0264-410X(15)00268.
    PubMed     Text format     Abstract available


  382. IQBAL S, Li R, Gargiulo P, Vellozzi C, et al
    Relationship between Guillain-Barre syndrome, influenza-related hospitalizations, and influenza vaccine coverage.
    Vaccine. 2015 Mar 3. pii: S0264-410X(15)00264.
    PubMed     Text format     Abstract available


  383. VAN BUYNDER PG
    Reply to letter to the editor.
    Vaccine. 2015;33:1234.
    PubMed     Text format    


  384. KOUTSONANOS DG, Esser ES, McMaster SR, Kalluri P, et al
    Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts.
    Vaccine. 2015 Mar 2. pii: S0264-410X(15)00153.
    PubMed     Text format     Abstract available


  385. STRELITZ B, Gritton J, Klein EJ, Bradford MC, et al
    Parental vaccine hesitancy and acceptance of seasonal influenza vaccine in the pediatric emergency department.
    Vaccine. 2015 Mar 2. pii: S0264-410X(15)00223.
    PubMed     Text format     Abstract available


    February 2015
  386. BEDNARCZYK RA, Chu SL, Sickler H, Shaw J, et al
    Low uptake of influenza vaccine among university students: Evaluating predictors beyond cost and safety concerns.
    Vaccine. 2015 Feb 26. pii: S0264-410X(15)00222.
    PubMed     Text format     Abstract available


  387. KIM C, Rhie S, Suh M, Kang DR, et al
    Pandemic influenza A vaccination and incidence of Guillain-Barre syndrome in Korea.
    Vaccine. 2015 Feb 26. pii: S0264-410X(15)00224.
    PubMed     Text format     Abstract available


  388. POEPPL W, Lagler H, Raderer M, Sperr WR, et al
    Influenza vaccination perception and coverage among patients with malignant disease.
    Vaccine. 2015 Feb 24. pii: S0264-410X(15)00207.
    PubMed     Text format     Abstract available


  389. VAN BUYNDER PG, Konrad S, Kersteins F, Preston E, et al
    Healthcare worker influenza immunization vaccinate or mask policy: Strategies for cost effective implementation and subsequent reductions in staff absenteeism due to illness.
    Vaccine. 2015 Feb 9. pii: S0264-410X(15)00093.
    PubMed     Text format     Abstract available


  390. HABER P, Moro PL, Cano M, Lewis P, et al
    Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014.
    Vaccine. 2015 Feb 9. pii: S0264-410X(15)00147.
    PubMed     Text format     Abstract available


  391. JACKSON ML, Rothman KJ
    Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness.
    Vaccine. 2015 Feb 5. pii: S0264-410X(15)00126.
    PubMed     Text format     Abstract available


  392. HMAMOUCHI I, Winthrop K, Launay O, Dougados M, et al
    Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: Data from the international COMORA cohort.
    Vaccine. 2015 Feb 5. pii: S0264-410X(15)00122.
    PubMed     Text format     Abstract available


  393. ROOS A, Roozendaal R, Theeuwsen J, Riahi S, et al
    Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies.
    Vaccine. 2015 Feb 5. pii: S0264-410X(15)00127.
    PubMed     Text format     Abstract available


  394. FRASCA D, Diaz A, Romero M, Landin AM, et al
    Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine.
    Vaccine. 2015 Feb 5. pii: S0264-410X(15)00128.
    PubMed     Text format     Abstract available


  395. BERTRAN K, Moresco K, Swayne DE
    Impact of vaccination on infection with Vietnam H5N1 high pathogenicity avian influenza virus in hens and the eggs they lay.
    Vaccine. 2015 Feb 2. pii: S0264-410X(15)00112.
    PubMed     Text format     Abstract available


    January 2015
  396. GRAVEL C, Elmgren C, Muralidharan A, Hashem AM, et al
    Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines.
    Vaccine. 2015 Jan 22. pii: S0264-410X(15)00053.
    PubMed     Text format     Abstract available


  397. KAPCZYNSKI DR, Esaki M, Dorsey KM, Jiang H, et al
    Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Vaccine. 2015 Jan 19. pii: S0264-410X(14)01671.
    PubMed     Text format     Abstract available


  398. CHEN CH, Chiu PJ, Chih YC, Yeh GL, et al
    Determinants of influenza vaccination among young Taiwanese children.
    Vaccine. 2015 Jan 19. pii: S0264-410X(15)00051.
    PubMed     Text format     Abstract available


  399. GORSE GJ, Falsey AR, Ozol-Godfrey A, Landolfi V, et al
    Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
    Vaccine. 2015 Jan 19. pii: S0264-410X(15)00044.
    PubMed     Text format     Abstract available


  400. QIN T, Yin Y, Wang X, Liu H, et al
    Whole inactivated avian Influenza H9N2 viruses induce nasal submucosal dendritic cells to sample luminal viruses via transepithelial dendrites and trigger subsequent DC maturation.
    Vaccine. 2015 Jan 19. pii: S0264-410X(15)00041.
    PubMed     Text format     Abstract available


  401. WOHLBOLD TJ, Hirsh A, Krammer F
    An H10N8 influenza virus vaccine strain and mouse challenge model based on the human isolate A/Jiangxi-Donghu/346/13.
    Vaccine. 2015 Jan 17. pii: S0264-410X(15)00045.
    PubMed     Text format     Abstract available


  402. BONMARIN I, Belchior E, Levy-Bruhl D
    Impact of influenza vaccination on mortality in the French elderly population during the 2000-2009 period.
    Vaccine. 2015 Jan 17. pii: S0264-410X(15)00042.
    PubMed     Text format     Abstract available


  403. BEYER WE, McElhaney J, Smith DJ, Monto AS, et al
    Reply: Letter to the editor, Cochrane rearranged.
    Vaccine. 2015;33:13-4.
    PubMed     Text format    


  404. OSTERHOLM MT, Kelley NS, Belongia EA, Jackson LA, et al
    Reply: Cochrane rearranged.
    Vaccine. 2015;33:12.
    PubMed     Text format    


    December 2014
  405. AIGBOGUN NW, Hawker JI, Stewart A
    Interventions to increase influenza vaccination rates in children with high-risk conditions-A systematic review.
    Vaccine. 2014 Dec 31. pii: S0264-410X(14)01641.
    PubMed     Text format     Abstract available


  406. MASSIN S, Ventelou B, Nebout A, Verger P, et al
    Cross-sectional survey: Risk-averse French general practitioners are more favorable toward influenza vaccination.
    Vaccine. 2014 Dec 26. pii: S0264-410X(14)01691.
    PubMed     Text format     Abstract available


  407. LE J, Orff EJ, Fulvini AA, Huang L, et al
    Development of high yield reassortants for influenza type B viruses and analysis of their gene compositions.
    Vaccine. 2014 Dec 26. pii: S0264-410X(14)01670.
    PubMed     Text format     Abstract available


  408. LIM C, Ang LW, Ma S, Lai FY, et al
    Comparison of severely ill patients with influenza A(H1N1)pdm09 infection during the pandemic and post-pandemic periods in Singapore.
    Vaccine. 2014 Dec 26. pii: S0264-410X(14)01672.
    PubMed     Text format     Abstract available


  409. ANTON A, Garcia S, Soldevila N, Gonzalez-Candelas F, et al
    Visualizing knowledge and attitude factors related to influenza vaccination of physicians.
    Vaccine. 2014 Dec 18. pii: S0264-410X(14)01640.
    PubMed     Text format     Abstract available


  410. ALTENBURG AF, Rimmelzwaan GF, de Vries RD
    Virus-specific T cells as correlate of (cross)-protective immunity against influenza.
    Vaccine. 2014 Dec 9. pii: S0264-410X(14)01611.
    PubMed     Text format     Abstract available


  411. KWONG JC, Pereira JA, Quach S, Pellizzari R, et al
    Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (relatives) pilot study: A cluster randomized trial.
    Vaccine. 2014 Dec 5. pii: S0264-410X(14)01597.
    PubMed     Text format     Abstract available


  412. NYHAN B, Reifler J
    Does correcting myths about the flu vaccine work? An experimental evaluation of the effects of corrective information.
    Vaccine. 2014 Dec 2. pii: S0264-410X(14)01542.
    PubMed     Text format     Abstract available


    November 2014
  413. BABU TM, Levine M, Fitzgerald T, Luke C, et al
    Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine.
    Vaccine. 2014;32:6798-804.
    PubMed     Text format     Abstract available


  414. THOMAS M, Wang Z, Sreenivasan CC, Hause BM, et al
    Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Vaccine. 2014 Nov 28. pii: S0264-410X(14)01573.
    PubMed     Text format     Abstract available


  415. CARVILLE KS, Grant KA, Sullivan SG, Fielding JE, et al
    Understanding influenza vaccine protection in the community: An assessment of the 2013 influenza season in Victoria, Australia.
    Vaccine. 2014 Nov 22. pii: S0264-410X(14)01544.
    PubMed     Text format     Abstract available


  416. TRANSFIGURACION J, Manceur AP, Petiot E, Thompson CM, et al
    Particle quantification of influenza viruses by high performance liquid chromatography.
    Vaccine. 2014 Nov 21. pii: S0264-410X(14)01566.
    PubMed     Text format     Abstract available


  417. LANGLEY JM, Frenette L, Jeanfreau R, Halperin SA, et al
    Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial.
    Vaccine. 2014 Nov 21. pii: S0264-410X(14)01543.
    PubMed     Text format     Abstract available


  418. NEROME K, Sugita S, Kuroda K, Hirose T, et al
    The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae.
    Vaccine. 2014 Nov 18. pii: S0264-410X(14)01533.
    PubMed     Text format     Abstract available


  419. CARTER DM, Bloom CE, Kirchenbaum GA, Tsvetnitsky V, et al
    Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine.
    Vaccine. 2014 Nov 18. pii: S0264-410X(14)01532.
    PubMed     Text format     Abstract available


  420. HU W, Zhang H, Han Q, Li L, et al
    A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
    Vaccine. 2014 Nov 18. pii: S0264-410X(14)01531.
    PubMed     Text format     Abstract available


  421. LYTRAS T, Kossyvakis A, Melidou A, Exindari M, et al
    Influenza vaccine effectiveness against laboratory confirmed influenza in Greece during the 2013-2014 season: A test-negative study.
    Vaccine. 2014 Nov 18. pii: S0264-410X(14)01529.
    PubMed     Text format     Abstract available


  422. RODGERS L, Pabst LJ, Chaves SS
    Increasing uptake of live attenuated influenza vaccine among children in the United States, 2008-2014.
    Vaccine. 2014 Nov 17. pii: S0264-410X(14)01530.
    PubMed     Text format     Abstract available


  423. PALACHE A, Oriol-Mathieu V, Abelin A, Music T, et al
    Seasonal influenza vaccine dose distribution in 157 countries (2004-2011).
    Vaccine. 2014;32:6369-6376.
    PubMed     Text format     Abstract available


  424. FREY SE, Bernstein DI, Brady RC, Keitel WA, et al
    Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.
    Vaccine. 2014 Nov 11. pii: S0264-410X(14)01502.
    PubMed     Text format     Abstract available


  425. KNUF M, Leroux-Roels G, Rumke HC, Abarca K, et al
    Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.
    Vaccine. 2014 Nov 11. pii: S0264-410X(14)01504.
    PubMed     Text format     Abstract available


  426. PELEG N, Zevit N, Shamir R, Chodick G, et al
    Seasonal influenza vaccination rates and reasons for non-vaccination in children with gastrointestinal disorders.
    Vaccine. 2014 Nov 11. pii: S0264-410X(14)01505.
    PubMed     Text format     Abstract available


  427. CHIT A, Roiz J, Briquet B, Greenberg DP, et al
    Expected cost effectiveness of high-dose trivalent influenza vaccine in US seniors.
    Vaccine. 2014 Nov 11. pii: S0264-410X(14)01479.
    PubMed     Text format     Abstract available


  428. OWUSU JT, Prapasiri P, Ditsungnoen D, Leetongin G, et al
    Seasonal influenza vaccine coverage among high-risk populations in Thailand, 2010-2012.
    Vaccine. 2014 Nov 7. pii: S0264-410X(14)01404.
    PubMed     Text format     Abstract available


  429. BROADBENT AJ, Santos CP, Paskel M, Matsuoka Y, et al
    Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates.
    Vaccine. 2014 Nov 6. pii: S0264-410X(14)01455.
    PubMed     Text format     Abstract available


  430. ROPERO-ALVAREZ AM, Whittembury A, Bravo-Alcantara P, Kurtis HJ, et al
    Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Vaccine. 2014 Nov 6. pii: S0264-410X(14)01460.
    PubMed     Text format     Abstract available


  431. HUANG D, Xia-Hou K, Liu XP, Zhao L, et al
    Rational design of medium supplementation strategy for improved influenza viruses production based on analyzing nutritional requirements of MDCK Cells.
    Vaccine. 2014;32:7091-7097.
    PubMed     Text format     Abstract available


  432. BOGGAVARAPU S, Sullivan KM, Schamel JT, Frew PM, et al
    Factors associated with seasonal influenza immunization among church-going older African Americans.
    Vaccine. 2014;32:7085-7090.
    PubMed     Text format     Abstract available


  433. GELLIN BG, Ampofo WK
    Seasonal and pandemic influenza vaccine: Demand, supply and vaccine availability.
    Vaccine. 2014;32:7037-7039.
    PubMed     Text format    


  434. SORUP S, Benn CS, Stensballe LG, Aaby P, et al
    Measles-mumps-rubella vaccination and respiratory syncytial virus-associated hospital contact.
    Vaccine. 2014 Nov 1. pii: S0264-410X(14)01175.
    PubMed     Text format     Abstract available


    October 2014
  435. BRADY RC, Hu W, Houchin VG, Eder FS, et al
    Randomized trial to compare the safety and immunogenicity of CSL Limited's 2009 trivalent inactivated influenza vaccine to an established vaccine in United States children.
    Vaccine. 2014;32:7141-7147.
    PubMed     Text format     Abstract available


  436. NESSLER K, Krzton-Krolewiecka A, Chmielowiec T, Jarczewska D, et al
    Determinants of influenza vaccination coverage rates among primary care patients in Krakow, Poland and the surrounding region.
    Vaccine. 2014;32:7122-7127.
    PubMed     Text format     Abstract available


  437. MERK H, Nylen G, Kuhlmann-Berenzon S, Linde A, et al
    Number needed to vaccinate to prevent hospitalizations of pregnant women due to inter-pandemic influenza in Sweden, 2003-2009.
    Vaccine. 2014;32:7135-7140.
    PubMed     Text format     Abstract available


  438. PREMATUNGE C, Corace K, McCarthy A, Nair RC, et al
    Qualitative motivators and barriers to pandemic vs. seasonal influenza vaccination among healthcare workers: A content analysis.
    Vaccine. 2014;32:7128-7134.
    PubMed     Text format     Abstract available


  439. LEHMANN BA, Ruiter RA, Chapman G, Kok G, et al
    The intention to get vaccinated against influenza and actual vaccination uptake of Dutch healthcare personnel.
    Vaccine. 2014;32:6986-6991.
    PubMed     Text format     Abstract available


  440. THOMAS RE
    Are influenza-associated morbidity and mortality estimates for those >/=65 in statistical databases accurate, and an appropriate test of influenza vaccine effectiveness?
    Vaccine. 2014;32:6884-6901.
    PubMed     Text format     Abstract available


  441. LITTMANN J
    How high is a high risk? Prioritising high-risk individuals in an influenza pandemic.
    Vaccine. 2014;32:7167-7170.
    PubMed     Text format     Abstract available


  442. ROSSEY I, Sedeyn K, De Baets S, Schepens B, et al
    CD8+ T cell immunity against human respiratory syncytial virus.
    Vaccine. 2014;32:6130-7.
    PubMed     Text format     Abstract available


  443. LAFOND KE, Tam JS, Bresee JS, Widdowson MA, et al
    International meeting on influenza vaccine effectiveness, 3-4 December 2012, Geneva, Switzerland.
    Vaccine. 2014;32:6591-6595.
    PubMed     Text format     Abstract available


  444. HUANG WT, Tang FW, Yang SE, Chih YC, et al
    Safety of inactivated monovalent pandemic (H1N1) 2009 vaccination during pregnancy: A population-based study in Taiwan.
    Vaccine. 2014 Oct 3. pii: S0264-410X(14)01322.
    PubMed     Text format     Abstract available


    September 2014
  445. SHARMA A, Wendland R, Sung B, Wu W, et al
    Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection.
    Vaccine. 2014;32:5761-8.
    PubMed     Text format     Abstract available


  446. RAGHUNANDAN R, Lu H, Zhou B, Xabier MG, et al
    An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization.
    Vaccine. 2014 Sep 27. pii: S0264-410X(14)01289.
    PubMed     Text format     Abstract available


    August 2014
  447. MALTEZOU HC, Poland GA
    Immunization of healthcare providers: a critical step toward patient safety.
    Vaccine. 2014;32:4813.
    PubMed     Text format    


  448. LEE JS, Kwon YM, Hwang HS, Lee YN, et al
    Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.
    Vaccine. 2014 Aug 27. pii: S0264-410X(14)01168.
    PubMed     Text format     Abstract available


  449. SANDE CJ, Cane PA, Nokes DJ
    The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants.
    Vaccine. 2014;32:4726-9.
    PubMed     Text format     Abstract available


    July 2014
  450. YAMAJI Y, Nakayama T
    Recombinant measles viruses expressing respiratory syncytial virus proteins induced virus-specific CTL responses in cotton rats.
    Vaccine. 2014;32:4529-36.
    PubMed     Text format     Abstract available


  451. WINSTON L, Wagner S, Chan S
    Healthcare workers under a mandated H1N1 vaccination policy with employment termination penalty: A survey to assess employee perception.
    Vaccine. 2014 Jul 1. pii: S0264-410X(14)00790.
    PubMed     Text format     Abstract available


    June 2014
  452. FITZSIMONS D, Badur S, Lernout T, Hendrickx G, et al
    How to reach health care workers? Viral Hepatitis Prevention Board meeting Barcelona, Spain, 15-16 November 2012.
    Vaccine. 2014 Jun 23. pii: S0264-410X(14)00873.
    PubMed     Text format     Abstract available


    April 2014
  453. SYDNOR E, Perl TM
    Healthcare providers as sources of vaccine-preventable diseases.
    Vaccine. 2014 Apr 8. pii: S0264-410X(14)00488.
    PubMed     Text format     Abstract available


  454. JONES BG, Sealy RE, Surman SL, Portner A, et al
    Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.
    Vaccine. 2014 Apr 7. pii: S0264-410X(14)00479.
    PubMed     Text format     Abstract available


    October 2013
  455. MALTEZOU HC , Poland GA
    Vaccination policies for healthcare workers in Europe.
    Vaccine. 2013 Oct 23. pii: S0264-410X(13)01424.
    PubMed     Text format     Abstract available


    May 2013
  456. DAVILA-PAYAN C , Swann J, Wortley PM
    System factors to explain H1N1 state vaccination rates for adults in US emergency response to pandemic.
    Vaccine. 2013 May 30. pii: S0264-410X(13)00684.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: